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Abstract 
Myosin motor proteins play fundamental roles in a multitude of cellular processes. 
Myosin generates force on cytoskeletal actin filaments to control cell shape, most 
dramatically during cytokinesis, and has a conserved role in defining cell polarity. Myosin 
contracts the actin cytoskeleton, ensuring prompt turnover of cellular adhesion sites, 
retracting the cell body during migration and development, and contracting muscle among 
diverse other functions. How myosins work, and why force generation is essential for their 
function, is in many cases an open question.  
Chapter 2 presents a structure-function analysis of the amoebozoan myosin 7 
(DdMyo7) in live Dictyostelium discoideum cells. DdMyo7 bears structural resemblance 
to human Myosin 7 (a protein involved in maintenance of the retina, stereocilia of the ear, 
and gut microvilli) but has functional similarity to human Myosin 10, a regulator of cell 
adhesion that is also essential in formation of actin-based structures called filopodia. 
Phylogenetic analysis of these related proteins shows that DdMyo7 is not directly related 
to any human myosin but rather represents a molecular ancestor of several vertebrate 
myosins (Myo7, Myo10 and Myo15). Functional analysis focused on rescue of myo7– cells. 
The two MyTH4-FERM domains were fully redundant in rescuing formation of filopodia. 
A conserved Myo7 regulatory motif in the C-terminal FERM domain was found to 
stimulate filopodia formation when mutated, establishing DdMyo7 as a filopodial motor 
with features of Myo7 and Myo10. A molecular chimera of DdMyo7 motor/lever arm 
region fused to the MF domain of human Myo10 partially rescued filopodia formation, 
iii 
suggesting the MF domain plays a similar role in filopodia in divergent organisms. 
Structural information must be combined with physiological data to understand the 
mechanism of myosin motor function. Structural studies have long focused on 
conventional myosin 2 as a model due to ease of protein expression and purification. This 
approach has yielded considerable data regarding the static structures and in vitro kinetics 
of the myosin mechanochemical cycle; however, high-resolution methods to observe the 
dynamics of myosin activation in cells have been lacking. Chapter 4 introduces methods 
and instrumentation for rapid, precise measurement of fluorescence lifetime. This is a 
necessary step toward Myo2-based live cell FRET sensors described in Chapter 5. 
Implications of this work for future studies of myosin physiological function are discussed 
in Chapter 6. 
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1 Mechanical Control of Cell Shape and 
Motion by Actin and Myosin  
1.1 Motor Proteins 
Living organisms have a fundamental requirement to control mechanical forces in the 
cell. Direct control is provided by molecular motor proteins. Rotary motor proteins unwind 
chromosomal DNA for replication and transcription, interact with ribosomal RNA for 
ribosome assembly, and perform ATP synthesis to power basic metabolism in both 
prokaryotes and eukaryotes (1, 2). Prokaryotes also employ rotary flagellar motors in cell 
motility, unlike eukaryotes (3). The complex subcellular architecture of eukaryotic cells is 
maintained not only by rotary motors but by dynamin, a twisting motor that facilitates 
endocytosis (4), and the cytoskeletal molecular motors, myosin, dynein, and kinesin (5–
10), that undergo linear motion to exert forces on polymeric tracks of cytoskeletal proteins 
while delivering cargo, producing cytoskeletal tension, and generating contractile forces. 
Myosin, dynein, kinesin, and dynamin are members of the P-loop NTPase superfamily, 
having conserved structural mechanisms for recognizing, binding, and hydrolyzing 
nucleotide triphosphate (11, 12). ATP is the preferred substrate for the cytoskeletal motors 
while GTP is used by dynamin and the distantly related Rho family of proteins (13–15)  
Dynein and kinesin motor proteins interact with microtubules (cylindrical polymers of 
heterodimeric tubulin subunits). Dynein motors move exclusively toward the microtubule 
minus end to transport cargo or to generate contractile forces in motile cilia (8). Kinesins, 
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in contrast, are structurally and functionally diverse with various kinesins able to move in 
minus or plus end directions as monomers, dimers, or multimeric teams. Kinesins play 
essential roles in microtubule-based transport and microtubule organization in mitosis and 
meiosis, as does cytoplasmic dynein (16–19). 
Myosin interacts with filamentous actin (F-actin) to generate motion toward the fast-
growing (‘barbed’) end of the filament, or more rarely, toward the ‘pointed’ end (Fig. 1). 
Myosin consists of a conserved catalytic domain containing an upper and a lower actin 
binding site, a nucleotide binding site, a buried 7-stranded β-sheet (‘transducer’), and a 
force-generating subdomain (‘converter’) that undergoes conformational change to rotate 
the light-chain binding domain (‘lever arm’) at a pivot adjoining the motor domain. Force 
is transmitted through the converter, lever arm, and C-terminal region (‘tail’) to the myosin 
cargo. Depending on specific interactions of the tail, the cargo may be a protein or lipid 
molecule that interacts with the tail, a signaling domain in the tail, or a myosin filament. 
Myosin binds and hydrolyzes ATP when detached from actin, but does not release 
reaction products until after the initial contact, a primarily electrostatic interaction with the 
lower actin binding site (‘weak binding’). Following release of inorganic phosphate, the 
upper site also binds actin in a stereospecific attachment (‘strong binding’). Myosin 
interacts most strongly with actin in the ADP-bound or nucleotide-free (apoenzyme) form. 
These states are highly populated when ATP stores are depleted following cell death (rigor 
mortis); thus, conditions favoring strongly bound myosin are termed rigor conditions. In 
contrast the high-ATP environment of a typical cell creates a condition of relaxation in 
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which myosin only briefly experiences strong binding to actin; nucleotide hydrolysis takes 
place primarily when myosin is detached from actin, and actin binding accelerates release 
of the hydrolysis products (20, 21). Curiously kinesin performs these events in the opposite 
order; ATP hydrolysis occurs while the motor is attached to its microtubule track, despite 
extensive structural homology of the core motor domains of myosin and kinesin (22). 
Myosin and actin are 
highly conserved across 
eukaryotic kingdoms. 
Actin is ubiquitous in 
eukaryotes where it is 
essential for control of cell 
shape and mechanical 
stiffness (cell motility) and 
for establishing cell 
polarity (24). Recent 
discovery of multiple actin 
homologs in Archaea 
suggests a molecular 
ancestor of actin predates the emergence of eukaryotes (25, 26). Myosin is widespread 
among all known branches of the eukaryotic tree of life but lacks the extreme structural 
conservation of its partner actin. Functional diversification appears to have occurred early 
 
Fig. 1. Force Generation by Actin-Myosin Interaction.  
Myosin is shown in the post-powerstroke conformation, strongly bound to 
an actin filament (left). Rotation of the light-chain binding domain (“Lever 
Arm”) in the downward direction (red arrow) results in movement of the 
motor domain toward the actin filament barbed end (green arrow). The 
lever arm is stabilized by two bound calmodulin-like proteins, the essential 
and regulatory light chains (ELC & RLC) Model from (23). 
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in eukaryotic evolution and continues to the present. Several ancient myosin classes are 
conserved between Amoebozoa, Fungi and animals including Myosin 1 (monomeric 
motors involved in actin-membrane interactions), Myosin 2 (dimeric filament-forming 
motors producing contractile forces), and Myosin 5 (dimeric transport motors) (27–29). 
These myosin classes are not universal as, for example, plants possess divergent myosin 
classes 8 and 11 (30–32). Some single-celled parasitic organisms such as Trichomonas 
vaginalis and Giardia intestinalis lack myosins but whether the loss is only possible for 
obligate parasites is unclear (33)1. Nevertheless, the widespread distribution of myosin 
classes 1, 2, and 5 suggests they descend from myosin genes present in the last eukaryotic 
common ancestor. 
1.2 Actin-based Cell Motility 
Actin is abundant in cells. The monomeric form of actin readily polymerizes at 
physiological concentrations of mono- or divalent cations. A key aspect of actin regulation 
is the prevention of spontaneous polymerization so that the chemical potential energy of 
actin assembly may be harnessed for force generation. Control of actin polymerization is 
achieved by limiting the free monomeric pool with G-actin binding proteins (binding to 
‘globular’ or monomeric actin) such as profilin and cofilin (conserved in animals, Fungi, 
amoebae, and plants) (34) as well as thymosin β4 (conserved in animals, and in amoebae 
                                                 
1 See also http://cymobase.org/cymobase for myosin sequences from a diverse range of organisms. 
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as actobindin (35)). Other proteins bind to F-actin (‘filamentous’ actin) either severing the 
filaments (cofilin, gelsolin and fragmin (36)) or sterically ‘capping’ their growing ends 
(37). Both types of F-actin binding protein are extensively conserved.  
Growth of actin filaments and larger actin-based structures is accomplished by actin 
nucleation factors, principally formins and the Arp2/3 complex. Although actin 
polymerization is thermodynamically favorable, nucleation of actin filaments requires a 
ternary collision complex that occurs quite slowly at physiological concentrations of free 
G-actin. Formins can accelerate formation of filaments de novo by recruitment and 
dissociation of the profilin-actin complex although the precise mechanism is obscure (38). 
The seven-membered Arp2/3 complex is a structural mimic of the ternary actin complex 
that is competent for polymerization when bound to the side of a pre-existing filament (24, 
39). The Arp2/3 complex generates branched or ‘dendritic’ actin filament arrays because 
Arp2/3 makes a 70° branch angle at the array nodes. Actin filament elongation takes place 
at a much faster rate than filament nucleation. The rate of actin polymerization in the cell 
is accordingly proportional to the number of uncapped (growing) filament ends. Thus, actin 
polymerization is under both thermodynamic control (limiting the concentration of free G-
actin) and kinetic control (limiting the concentration of free F-actin barbed ends). 
Growth of dendritic actin networks via Arp2/3 provides the driving force for cell 
migration through expansion of lamellipodia and pseudopodia. The Arp2/3 complex is 
regulated by two proteins, WASP and WAVE, that use a common mechanism yet operate 
in distinct pathways (40–42). The VCA motif of WASP/WAVE binds and activates the 
6 
Arp2/3 complex. WASP is regulated by direct binding to the Cdc42 GTPase while WAVE 
functions as part of the five-membered complex (WRC) regulated by interaction of the 
Sra1 subunit with Rac GTPases (42, 43)1. These small GTPases act as molecular switches 
that activate actin polymerization in response to upstream signaling receptors, mediated by 
physical association of WASP and/or WAVE with Nck family signal adaptors (44, 45).  
1.3 Conventional Myosins: Continuous Contraction 
Class 2 myosins are known as “conventional” myosins because early studies of actin 
and myosin concentrated on skeletal muscle preparations containing Myosin 2 protein. 
Conventional myosins generate the contractile forces of cell migration, cytokinesis and 
muscle contraction. A long (~ 100 nm) coiled coil region, adjacent to the lever arm, 
promotes dimerization followed by oligomerization of antiparallel filaments. This 
antiparallel configuration orients the myosin motor domains such that the working stroke 
is directed inward, toward the center of the filament. The average motion contracts the actin 
network since the geometry of the actin-myosin bond only permits motion in one direction. 
The opposite configuration, where myosin filaments generate expansive forces, does not 
occur presumably because the actin network itself generates sufficient expansion2. 
                                                 
1 Consisting of SCAR/WAVE (WAVE1 or WAVE2), Sra1/PIR121 (CYFIP2), Abi (ABI1 or ABI2), 
Nap1/Nap125/Hem-2/Kette (NCKAP1), and HSPC300/HSPC3000/Brick-1 (BRK1). Standard HGNC 
symbols italic, see: http://www.genenames.org/. 
2 Non-filamentous myosins, however, can generate expansive forces within actin networks (46). 
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Conventional myosin genes are extensively duplicated in bilaterian animals supporting 
increasingly specialized muscle tissue types (52, 53). Mammals have three muscle types: 
smooth muscle of the uterus, gastrointestinal and circulatory systems, and two striated 
types, skeletal muscle and cardiac muscle. Striated muscles are named for their regular 
Table 1. Human Conventional Myosin Genes 
Gene1 Myosin class HGNC  CyMoBase  Location Accession No. UniProt  
MYH1 Skeletal IIx 7567 Mhc1 17p13.1 NM_005963 P12882 
MYH2 Skeletal IIa 7572 Mhc2 NM_017534 Q9UKX2 
MYH3 Skeletal embryonic 7573 Mhc3 NM_002470 P11055 
MYH4 Skeletal IIb 7574 Mhc4 NM_017533 Q9Y623 
MYH8 Skeletal perinatal 7578 Mhc8 NM_002472 P13535 
MYH10 Non-muscle IIb 7568 Mhc10 NM_001256012 P35580 
MYH13 Skeletal extraocular 7571 Mhc13 NM_003802 Q9UKX3 
MYH6 Atrial cardiac 7576 Mhc6 14q11.2 NM_002471 P13533 
MYH7 Skeletal slow &  
Ventricular cardiac 
7577 Mhc7 NM_000257 P12883 
MYH9 Non-muscle IIa 7579 Mhc9 22q12.3 NM_002473 P35579 
MYH11 Smooth muscle 7569 Mhc11 16p13.11 NM_001040113 P35749 
MYH14; 
MYH17, 
formerly 
Non-muscle IIc 23212 Mhc16 19q13.33 NM_024729 Q7Z406 
MYH7B; 
MYH14, 
formerly 
Embryonic/perinatal 
myosin of unknown 
function (47–51) 
15906 Mhc14 20q11.22 NM_020884 A7E2Y1 
MYH15 Skeletal extraocular 
perinatal (47, 48) 
31073 Mhc15 3q13.13 XM_036988 Q9Y2K3 
MYH16; 
MYH5, 
formerly 
Pseudogene relative of 
invertebrate muscle 
myosin (47)  
31038 Mhc20 7q22.1 NR_002147  
1 The following gene names are retired: MYH5 (=MYH16), MYO12 (=MYO5A), and MYH17 (=MYH14) 
2 CyMoBase v 2.0.0 accessed 19 Nov 2016, see http://cymobase.org/cymobase  
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striations formed by sarcomeric arrays of actin and myosin filaments.  Smooth muscle 
myosin is divergent from the striated muscle myosins, being more closely related to non-
muscle myosins employed in cytokinesis and cell migration (28, 54, 55). Humans possess 
1 smooth, 3 non-muscle, and 10 striated muscle myosin genes (Table 1), each with kinetic 
and regulatory adaptations in many cases accompanied by tissue-specific ELC and RLC 
gene expression (56). Intracellular calcium is the primary regulator of conventional 
myosin, either by direct binding of the ELC (invertebrate muscle myosins and Physarum 
myosin 2); indirectly by calmodulin-mediated activation of myosin light chain kinase 
(smooth muscle myosins, non-muscle myosin and vertebrate striated muscle myosins); or 
through the troponin-tropomyosin complex (a unique adaptation of vertebrate striated 
muscle). 
1.4 Unconventional Myosins: Tension and Transport 
Non-class 2 (‘unconventional’) myosins exhibit diverse, principally cytosolic 
functions including building and maintaining actin-based protrusions, recognizing and 
delivering subcellular cargo molecules, regulating the formation of cell-substrate adhesion 
complexes, and acting as mechanically sensitive signaling molecules (Table 2). 
Myosin 1 is the largest unconventional myosin class with 8 representatives in humans. 
Myosin 1 motors generate tension across actin filaments and lipid membranes, either 
promoting membrane tension, fission and fusion, or providing mechanical feedback.  
9 
Myosin 5 and Myosin 6 function primarily as cargo delivery molecules, particularly 
Table 2. Human Unconventional Myosin Genes 
Gene1 Primary Function Specialization HGNC  Accession No. UniProt 
MYO1A Generate and sense 
tension at actin-
membrane 
interfaces (57) 
Vesicle transport 7595 NM_005379 Q9UBC5 
MYO1B Vesicle transport 7596 NM_012223 O43795 
MYO1C Force-sensing 7597 NM_001080779 O00159 
MYO1D Vesicle fusion 7598 NM_001303279 O94832 
MYO1E Endocytosis 7599 NM_004998 Q12965 
MYO1F Decreased adhesion 7600 NM_012335 O00160 
MYO1G Lymphocytes 13880 NM_033054 B0I1T2 
MYO1H Unknown 13879 NM_173597 Q8N1T3 
MYO3A Transport (58, 59) Stereocilia 
elongation 
7601 NM_017433 Q8NEV4 
MYO3B 15576 NM_001083615 Q8WXR4 
MYO5A Transport (60–62) Vesicle secretion 7602 NM_000259 Q9Y4I1 
MYO5C Vesicle secretion 7604 NM_018728 Q9NQX4 
MYO5B Receptor trafficking 7603 NM_001080467 Q9ULV0 
MYO6 Transport (63) Retrograde 7605 NM_004999 Q9UM54 
MYO7A Cargo Transport & 
Scaffold (64–66) 
Stereocilia & retina 7606 NM_000260 Q13402 
MYO7B Microvilli 7607 XM_291001 Q6PIF6 
MYO9A RhoGAP (regulator 
of F-actin) (67, 68) 
Cell-cell adhesion 7608 NM_006901 B2RTY4 
MYO9B Decreased invasion 7609 NM_001130065 Q13459 
MYO10 Transport (69–72) Filopodia formation 7593 NM_012334 Q9HD67 
MYO15A Transport (73) Stereocilia 
elongation 
7594 NM_016239 Q9UKN7 
MYO15B Pseudogene (74)  14083 NR_003587  
MYO16 Scaffold (75, 76) Cell migration 29822 NM_015011 Q9Y6X6 
MYO18A Scaffold; may be 
inactive (77) 
Non-muscle myosin 
filament assembly 
31104 NM_078471 Q92614 
MYO18B Unknown (78–81) Tumor suppressor 18150 NM_032608 Q8IUG5 
MYO19 Transport (82) Mitochondrial outer 
membrane-associated 
26234 NM_025109 Q96H55 
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in vesicle transport. Myosins 3, 7, 10, 15, and 19 function as cargo transporters although 
these motors may have additional roles in generating local tension or acting as 
mechanically sensitive signal adaptors. Myosin 9 is unusual in that its ‘cargo’, a RhoGAP 
signaling domain, is part of the tail. Myosins 16 and 18 are incompletely characterized but 
may function as signal adaptors or scaffolds in cell migration (Myo16) and non-muscle 
myosin assembly (Myo18A). 
The diversity of myosin genes in the human genome reveals not only a high degree of 
tissue-specific adaptation, in many cases conserved in vertebrates, but also the wide range 
of mechanical and biochemical functions that myosins have adopted. To better understand 
the origins of myosin diversity in animals, it is helpful to turn to a model organism. 
1.5 Dictyostelium is a Developmental Model Organism 
Dictyostelium discoideum is an amoebozoan model organism for understanding cell 
migration, cytokinesis, and the origins of multicellular development (83, 84). The 
Amoebozoa are the closest living relatives of Opisthokonta (Fig. 2), a phylogenetic 
supergroup that includes Fungi, Metazoa (animals), and their unicellular relatives.  
Dictyostelium amoebae are aerobic migratory cells that lead a foraging lifestyle in 
temperate habitats such as the leaf litter and surface soil of deciduous forests. The 
amoeboid cells are protected by a thick glycoprotein coat that permits nonspecific adhesion 
to objects encountered during migration. The cells subsist primarily by phagocytosis of 
bacteria that are recognized upon contact. The processes of migration and phagocytosis are 
11 
driven by actin-based cell motility with essential roles for myosin motors, pathways that 
are largely conserved in humans and most closely resemble the phagocytic behavior of 
human macrophages. 
When food becomes scarce, a developmental program initiates secretion of cAMP-
producing exosomes accompanied by a cAMP-degrading phosphodiesterase (87–90). 
These two enzymes establish a reaction-diffusion mechanism that generates [cAMP] waves 
propagating in the moist environment (91, 92). The amoebae direct their migration toward 
 
Fig. 2. Phylogenetic Classification of Eukaryotes. 
The Ameobozoa share a common ancestor with Fungi and animals (Metazoa). The SAR group shares a 
common ancestor with plants (Archaeplastida = Viridiplantae). Figure reprinted with permission and 
amended (85, 86); © 2012 International Society of Protistologists. 
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increasing [cAMP] leading them to meet and form multicellular aggregates.  
In the later phases of development, cell-cell cohesion organizes the cell mass into a 
pseudoplasmodium or ‘slug’ (93–95). The slug is strongly phototactic and may make a 
second migration to find a better environment for dissemination of spores. During the final 
phase the slug becomes a fruiting body (sorus) differentiating into somatic cells that form 
a rigid cellulose stalk several millimeters tall supporting a spherical mass of spore cells. 
The stalk cells experience autophagy-mediated death while the spore cells, themselves 
encased in a cellulose coat, germinate 
when environmental conditions are 
favorable. Myosins are critically 
involved in tension generation to 
support migration of individual cells, as 
well as generating forces used to sort 
differentiating cells by type within the 
slug and to elevate the spores and stalk 
cells within the sorus. 
Myosins have conserved physiological functions in Dictyostelium, represented by 
seven Myosin 1, one Myosin 2, and two Myosin 5 (Fig. 3, Table 3). The Dictyostelium 
Myosin 2 (DdMhcA) is structurally and functionally homologous to human non-muscle 
myosins, with additional essential roles in development of the slug and fruiting body, and 
has been used as a model in numerous structural and kinetic studies. Myosins 1, 2, and 5 
 
Fig. 3. Principal Myosin Classes in Dictyostelium. 
Dictyostelium discoideum possesses Myosin 1 (represented 
by Myo1B), Myosin 2 (MHCA), Myosin 5 (represented by 
MyoH), and Myosin 7 (MyoI). See also Table 3. 
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are ubiquitous in Amoebozoa as they are in animals and many Fungi. 
Dictyostelium possess a Myosin 7 (DdMyo7) that has critical roles in phagocytosis, 
calcium-dependent cell-cell cohesion, spore morphogenesis and filopodia formation. 
Table 3. Amoebozoan Myosin Genes 
Myosin 
class 
Primary 
Function 
Gene in 
Dictyostelium 
discoideum 
ENA 
Accession  
UniProt 
ID 
Gene in 
Acanthamoeba 
castellanii 
UniProt ID  
Myo1 Generate and 
sense tension at 
actin-membrane 
interfaces 
myoA  EAL67246 P22467 ACA1_362570 L8GGA4 
myoB  EAL62866 P34092 MIB P19706 
myoC EAL69121 P42522 MIC 
MICHC 
P10569 
O61080 
myoD EAL69474 P34109 ACA1_173680 L8HHR2 
myoE EAL63071 Q03479 - - 
myoF EAL62822 P54695 - - 
myoK  EAL70180 Q9XXV8 AcMyo1G1 - 
Myo2 Contraction mhcA EAL64202 P08799 ACA1_326740 L8HMU1 
Myo4 Unknown (96) - - - HMWMI P47808 
Myo5 Cargo transport myoH EDR41040 P54696 ACA1_224860 
ACA1_322090 
L8GSY9 
L8GN06 myoJ  EAL71208 P54697 
Myo7 Filopodia 
formation and 
cell-substrate 
adhesion 
myoI EAL70120 Q9U1M8 ACA1_066150 
ACA1_084860 
ACA1_108600 
ACA1_175100 
ACA1_264090 
ACA1_265440 
L8GX00  
L8HKE9 
L8GF39 
L8HK97 
L8H3E7 
L8H1F4 
Myo44 Chemotaxis in 
social amoebae 
(97, 98) 
myoG EAL69262 Q86AC8 - - 
Myo45 Unknown (99); 
RhoGEF activity 
myoM EAL61255 Q9TW28 - - 
1 CyMoBase v 2.0.0 accessed 19 Nov 2016, see http://cymobase.org/cymobase 
14 
DdMyo7 has similarities to human Myosin 10 as well as Myosin 7, a relationship that is 
the focus of the next chapter. This myosin is well-represented throughout Amoebozoa, with 
representatives in Physarum polycephalum and the solitary amoeba Acanthamoeba 
castellanii. 
Two myosin classes unique to Amoebozoa are represented by Dictyostelium Myosin 
44 and Myosin 45. Myo44 is essential for cAMP-dependent chemotaxis and development. 
Myo44, a paralog of Myosin 7, is present only in the social amoebae (Dictyostelia). 
Although it is possible that this myosin was lost in other lineages, the critical function of 
Myo44 in multicellular development argues that it arose by duplication of Myosin 7 during 
evolution of the social amoebae. Myo45 is a myosin of unknown function that contains a 
RhoGEF domain affecting local actin dynamics under conditions of hyperosmotic stress. 
Myo45 is common in social amoebae and has also been identified in the solitary amoeba 
Balamuthia mandrillaris1, suggesting that the class arose early in amoebozoan evolution. 
Comparison of the myosin gene family in humans with the myosins in Dictyostelium 
shows broad structural and functional conservation of Myosin 1, 2, and 5. While 
considerable specialization is seen within these classes, Myosin 1 is essential for actin-
membrane interactions in both organisms, while non-muscle Myosin 2 is involved in 
contraction and Myosin 5 plays essential roles in intracellular transport. However, the 
                                                 
1 CyMoBase v 2.0.0 accessed 19 Nov 2016, see http://cymobase.org/cymobase 
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function of Dictyostelium Myosin 7, and how it relates to human Myosin 7, is less clear. 
1.6 MyTH4-FERM Myosins 
Myosins of class 4, 7, 10, 15, 22, 32, 44 and 55 contain MyTH4-FERM domains in 
their tail regions. It is not known whether these myosins evolved from a single ancestral 
myosin or whether the MF domain has been introduced on independent occasions, but the 
roles of MF domain in regulating cytoskeletal proteins suggests common adaptive 
pressures at work. The MyTH4 domain is a bundle of six helices that possesses 
microtubule-binding activity (100–102). FERM domains contain 3 closely packed globular 
subdomains that can bind diverse specific targets and often have F-actin binding activity 
(102–104). MyTH4-FERM domains form a compact supramodule in myosins, the 
conserved plant kinesin zwichel (105), and the conserved holozoan gene max-1/PLEKHH 
(106). 
The physiological functions of several classes of MF myosin are unknown. These 
include Myo4 (found in solitary amoebae and the SAR group), Myo22 (arthropods, 
choanoflagellates, and some Fungi), Myo32 (SAR group), and Myo55 (apicomplexans 
such as the malarial parasite Plasmodium falciparum). Uncertainty persists in part because 
of the narrow phylogenetic distribution of these myosins and lack of genetic model systems 
to investigate their function. 
MF myosins in mammals have been described in a rich literature identifying roles in 
growth and maintenance of actin-based structures such as stereocilia (Myo7A & Myo15), 
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retinal microvilli/calyceal processes (Myo7A), gut microvilli (Myo7B), filopodia, 
invadopodia, and podosomes (Myo10)1. Each of these structures is characterized by tight 
bundles of actin filaments with barbed ends aligned at their distal tip. Loss of the specific 
MF myosin causes defects ranging from severe disorganization (stereocilia, microvilli) to 
complete loss (filopodia). These MF myosins thus appear to have similar functions in 
organization of actin-based structures despite vast differences in the time scale of these 
structures, ranging from decades (stereocilia) to as short as a few seconds (filopodia). 
A central question concerning MF myosins is whether cargo transport is an essential 
physiological function. Myosin 7A & 7B appear to have complementary, but distinct, roles 
as transporters and as signal scaffolds. Myo7 forms a multiprotein complex, including a 
cadherin adhesion receptor. The motor activity of Myo7 appears to drive the complex to 
the barbed end while ensuring the complex assembles in the correct location (107, 108). 
Myosin 10 appears to have separated cargo transport from filopodia formation functions, 
as it traffics the BMP receptor (109), netrin receptor (110), and V/E cadherin (111) at the 
tips of filopodia independently of filopodia formation. However the Myosin 10 tail is 
essential in both cases as expression of Myosin 10 lacking the MF domain cannot rescue 
the dorsal filopodia of HeLa cells (112, 113). This raises the question of how the MF 
domain participates in filopodia formation, whether by helping to generate local tension 
through binding F-actin filaments or by some other interaction. This has been difficult to 
                                                 
1 See Table 2 for references. 
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address in human cells due to the lack of Myo10-null cell lines. Furthermore, the 
Dictyostelium Myosin 7 (DdMyo7) has an essential role in filopodia formation and 
Dictyostelium cells express a broadly homologous complement of proteins involved in 
actin-based motility, and deletion of many of these proteins alters filopodia number, length 
and/or cell adhesion (Table 4). This functional conservation suggests that the mechanism(s) 
of filopodia formation have been conserved, but the role of MF myosins in this process 
remains mysterious.  
Understanding the physiological function of myosins will require both a molecular 
understanding of how these motors are localized and activated in the cell and a biophysical 
understanding of how myosin activation and force generation are involved in the 
physiological mechanism (e.g., filopodia formation). To begin to understand how MF 
myosins function in vivo, DdMyo7 was used as a molecular genetic model to investigate 
questions of how filopodial myosins function.  
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Table 4. Filopodial Proteins in Amoebozoa. 
Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
Motors 
DdMyo7 myoI Myosin; IQ (×4); 
SAH; MyTH4-
FERM (×2); SH3 
Phagocytosis
, Filopod 
formation, 
cell-cell 
adhesion 
Filopodia tip, 
leading edge, 
cytosol, cell-
cell contacts 
No filopodia, decreased cell-
substrate adhesion, loss of 
Ca-dependent cell-cell 
adhesion, decreased particle 
adhesion and phagocytosis, 
decreases in cell size and 
spore germination 
Talin A Post-lever arm 
region required 
for filopodia tip 
localization; 
MF required for 
filopod 
formation 
(114–
116) 
MhcA 
(Myosin 2) 
mhcA Myosin; IQ (×2); 
Coiled coil 
Cortical 
tension, 
contraction, 
cytokinesis 
Actin cortex, 
cytosol, 
cleavage 
furrow 
No-phos (3xAla): decreased 
filopodia  
Pseudo-phos (3xAsp): 
increased filopodia 
ELC, RLC,  
MHCK 
Pseudo-phos 
mutant unable to 
assemble as 
filaments 
(117–
119)  
 
Myo1B myoB Myosin; IQ; 
MyTH1; MyTH2; 
SH3 
Membrane 
anchoring 
and tension 
sensing 
Filopodia, 
actin cortex 
Defects in phagocytosis and 
development, control of 
pseudopod formation, and 
endocytic recycling 
CARMIL 
(120) 
 
 (121–
127) 
 
Myo1D myoD Myosin; IQ; 
MyTH1; MyTH2; 
SH3 
Membrane 
anchoring 
Filopodia, 
actin cortex 
Unknown; compound 
phenotype with myoE and 
myoF  
  (123, 
128–
130)  
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
Actin Polymerization Factors 
Dia2 forH FH3; FH1; FH2 
(×2) 
Actin 
filament 
anti-capping 
(barbed end) 
Filopodia tip, 
cytosol 
Decreased filopodia number 
and length, increased cell 
speed; dia2+: increased 
filopodia number and length 
Profilin II 
(FH1); 
Rac1.GTP; 
VASP 
(FH1-FH2) 
FH1-FH2 
required for 
filopodia tip 
localization and 
VASP binding 
(131) 
VASP vasp EVH1 (incl. WH1); 
EVH2 (=WH2); 
Coiled coil 
 
Actin 
filament 
bundling and 
nucleation 
Filopodia tip, 
leading edge, 
cell-cell 
contacts, 
cytosol 
No filopodia, decreased 
substrate & particle adhesion, 
cell size and speed 
vasp+: increased filopod 
number; vaspΔEVH1+: 
numerous short filopodia 
Dia2; 
Profilin III; 
Unidentified 
kinase(s) 
Pseudo-phos 
mutant: 
Decreases in 
filopodia and F-
actin 
polymerization  
(115, 
132–
134) 
SCAR/ 
WAVE  
scrA Core member of a 
heteropentameric 
complex (WRC) 
Actin 
nucleation at 
Arp2/3 
branches 
Filopodia tip, 
pseudopodia, 
cell-cell 
contacts 
Not essential for filopodia  Arp2/3 Similar 
localization for 
all complex 
components 
(42, 
135, 
136) 
WIP wipA WH2 Actin 
protrusions 
Actin cortex, 
cytosol 
Knockdown has decreased 
filopodia number, decreased 
F-actin; wipA+ has increased 
filopodia number, increased 
F-actin at leading edge 
WASP, 
VASP (via 
WH1) 
WIP does not 
translocate to 
cortex in VASP-
null cells  
(132, 
137, 
138) 
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
WASP wasA WH1; CRIB; WH2 Actin 
nucleation at 
Arp2/3 
branches 
Actin cortex, 
enriched at 
leading edge 
wasATK: Chemotaxis defects, 
decreased actin leading edge; 
inhibition with wiskostatin 
does not alter filopodia 
WIP 
(WH1); 
Arp2/3; 
RacC 
(CRIB) 
 Filopodia data 
not reported for 
wasATK cells 
(42, 
139–
141) 
GTPases and Regulatory Proteins 
Rac1 rac1a,b,
c 
Rho GTPase Regulation 
of actin  
Plasma 
membrane 
anchored, also 
in cytosol 
rac1a+: increased filopod 
number; CA mutant: no 
filopodia; CI mutant: 
numerous short filopodia 
DGAP1, 
Dia2, PakA, 
Filamin 
rac1a+ yields 
strongest 
phenotype; 
analogous to 
mammalian Rac 
(142–
144) 
RacC racC Rho GTPase Regulation 
of actin 
Pseudopodia, 
filopodia; 
punctate 
Defects in chemotactic 
signaling, speed and 
persistence 
WASP Analogous to 
Cdc42 
 
 
(145) 
RacG racG Rho GTPase Regulation 
of actin 
Plasma 
membrane, 
cytosol 
racG+: very numerous 
filopodia 
  (146) 
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
RacH racH Rho GTPase Regulation 
of actin 
ER and Golgi 
membranes 
Defects in endocytosis and 
exocytosis 
 Induces long 
filopodia when 
targeted to 
membrane with 
RacG motif 
(147) 
Zizimin zizB DHR1 (binds 
PIP3); DHR2 
(GEF) 
 
RhoGEF 
(Dock 
family) 
Filopodia (not 
enriched at 
tip), 
membrane 
Small decreases in cell speed 
and time to develop; 
Defective fruiting bodies 
zizB+: Doubled number of 
filopodia, defect in 
cytokinesis 
Rac1; 
formin A; 
Arp2/3  
Upregulated in 
chemotactic 
cells 
(148) 
MEGAP1 mgp1-4 F-BAR 
RhoGAP 
Tubulation, 
curvature in 
vacuole 
network 
Cytosol, 
transiently to 
contractile 
vacuole  
More numerous & slowly 
contracting vacuoles; 
increased filopodia number; 
motility & development 
defects 
 Unclear if GAP 
is active; protein 
function 
attributed to 
F-BAR 
(149) 
RasG rasG Ras GTPase Regulation 
of growth 
and 
development 
Plasma 
membrane, 
actin cortex, 
cytosol 
Numerous long filopodia 
(compare acapA+); 
CA mutant: reduced filopodia 
number 
  (150, 
151) 
DGAP1 rgaA IQ (×5 or ×6); 
RasGAP; Coiled 
coil 
RasGAP  Cytosol, actin 
cortex, leading 
& trailing 
Increased filopodia number, 
cell speed 
rgaA+: decreased filopod 
Binds Rac1 
but inactive; 
GAP active 
IQGAP 
homolog but 
light chains 
(144, 
152) 
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
edges number, cell speed for RasD  unidentified; 
lacks CH 
domain 
Arf arfA Arf GTPase  Regulation 
of vesicle 
transport, 
endocytosis 
Membrane, 
cytosol 
CA mutant: decreased filopod 
number and/or length 
 Localizes to 
centrosomes 
during mitosis 
(153) 
ArfGAP A acapA BAR; PH; 
ArfGAP; Ankyrin 
(×2) 
ArfGAP Membrane, 
cytosol, 
filopodia (not 
in tips) 
Decreased filopodia number 
& length; slower cell speed 
acapA+: increased filopodia 
number & length 
ArfA  (153, 
154) 
SecG secG Ankyrin (×15); 
Sec7; PH 
ArfGEF n.d. secG+: high basal F-actin in 
polarized cells, ‘spiky’ 
appearance 
  (155) 
Rap1 rapA Rap GTPase Regulation 
of adhesion 
proteins 
Plasma 
membrane, ER 
and Golgi 
CA mutant: increased cell-
substrate adhesion; CI 
mutant: Decreased adhesion 
TalB 
Phg2 
 (156–
159) 
RapGAP9 rapgap9  RapGAP Unclear Increased filopodia number 
and F-actin, increased cell-
substrate adhesion 
Rap1  (160) 
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
Cell Adhesion Proteins 
Talin A talA FERM Links cell-
substrate 
adhesions to 
actin 
Filopodia tip, 
actin cortex, 
cytosol 
Decreased cell-substrate 
adhesion, decreased particle 
adhesion and phagocytosis, 
cytokinesis defect, wt filopod 
number 
DdMyo7 Myo7 binds and 
stabilizes in cell 
lysates; large 
decrease in 
myo7– cells 
(161–
164) 
Paxillin B paxB LD (×4)  
LIM (×4) 
Maturation 
of cell-
substrate 
adhesions 
Filopodia; 
adhesion sites; 
cytosol 
Decreased cell-substrate 
adhesion, morphogenesis and 
development defects 
Phospho-
lipase D 
 (165–
167) 
FrmA frmA FERM (×2) Turnover / 
detachment 
of adhesions 
Filopodia tip; 
adhesion sites; 
cytosol 
Increased cell spreading, 
failure to detach from 
substrate 
  (168) 
Actin-Binding Proteins 
ABP-34 abpB EF-Hand; unique 
actin binding 
domain 
Actin cross-
linking 
Filopodia, 
pseudopodia, 
phagocytic 
cups, cell-cell 
contacts 
Numerous short filopodia 
(DH1 KO) or long, branched 
filopodia (Ax2 KO) with 
defects in detachment; 
increased migration 
persistence 
 Ca2+-sensitive; 
Short filopodia 
in fimA–/abpB–; 
normal 
phagocytosis  
(169–
173) 
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
EF-1α efaA1  Actin 
bundling; 
protein 
translation 
Filopodia, 
actin cortex, 
cytosol 
  Known as ABP-
50 in older 
literature 
(174–
176) 
Actobindin abnA-C WH2-WH2 Actin 
binding 
Actin cortex, 
enriched at 
base of 
filopodia in A. 
castellanii 
Unknown  abnC is a 
duplicate of 
abnB 
(177, 
178) 
Capping 
protein 
acpA,B  Barbed-end 
actin capping 
 Hypomorph: numerous short 
filopodia; cells stationary in 
mounds 
 Heterodimeric 
complex 
(37, 
179) 
Profilin I/II proA, B  G-actin 
binding 
 Decreased filopod number 
and length 
Dia2 
(Profilin II) 
 
 
 
 
 
 
 
 
 
(131) 
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Protein Gene Architecture Activity Localization Null and Other Phenotypes  Interaction Notes Ref. 
Kinases 
PakD pakD CH; CRIB; Ser/Thr 
kinase 
Ser/Thr 
Kinase 
Actin cortex, 
plasma 
membrane 
Decreased filopodia number, 
decreased cAMP-stimulated 
F-actin response 
  (180) 
Phg2  phg2 Ras-binding 
domain; Ser/Thr 
kinase 
Ser/Thr 
kinase 
Actin cortex, 
plasma 
membrane 
KAx3 KO: Increased filopod 
number, F-actin, increased 
adhesion; DH1 KO: loss of 
filopodia but not adhesion 
Rap1; 
Ras-binding 
required to 
rescue 
filopodia 
KAx3 KO: 
increased 
adhesion; DH1 
KO: decreased 
adhesion (glass) 
(156, 
159, 
181, 
182) 
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2 MyTH4-FERM Myosins Have an Ancient 
and Conserved Role in Filopodia 
Formation1  
2.1 Chapter Summary 
The formation of filopodia in Metazoa and Amoebozoa requires the activity of Myo10 
in mammalian cells and DdMyo7 in the social amoeba Dictyostelium. However, the exact 
role(s) of these MyTH4-FERM myosins (MF; myosin tail homology 4 - band 4.1, ezrin, 
radixin, moesin) in initiation and elongation of filopodia are not well defined and may 
reflect conserved functions among phylogenetically diverse MF myosins. Phylogenetic 
analysis of myosin MF domains suggests a single ancestral MF myosin existed with a 
structure similar to DdMyo7, that has two MF domains, and subsequent duplications in the 
Metazoan lineage produced its functional homologue Myo10. The essential functional 
features of the DdMyo7 myosin were identified using quantitative live cell imaging to 
characterize the ability of various mutants to rescue filopod formation in myo7 null cells. 
The two MF domains were found to function redundantly in filopod formation with the C-
terminal FERM domain regulating both the number of filopodia and their elongation 
                                                 
1 Reprinted from: K.J. Petersen, H.V. Goodson, A.L. Arthur, G.W.G. Luxton, A. Houdusse, M.A. Titus, 
MyTH4-FERM myosins have an ancient and conserved role in filopod formation, PNAS. (2016) 201615392. 
doi:10.1073/pnas.1615392113. 
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velocity. DdMyo7 mutants consisting solely of the motor plus a single MyTH4 domain 
were found to be capable of rescuing formation of filopodia, establishing the minimal 
elements necessary for the function of this myosin. Interestingly, a chimeric myosin with 
the Myo10 MF domain fused to the DdMyo7 motor was also capable of rescuing filopod 
formation in the myo7 null, supporting fundamental functional conservation between these 
two distant myosins. Together, these findings reveal that MF myosins have an ancient and 
conserved role in filopod formation.  
2.2 Introduction 
Cells interact with their environment through protrusions such as filopodia that form 
in response to extracellular cues and mediate initial contact with the substrate. Filopodia 
are slender actin-filled membrane projections that are highly dynamic, growing and 
shrinking from peripheral regions of cells, such as lamellipodia and the dorsal surface 
(183). A wide variety of cell types including amoebae such as Dictyostelium discoideum 
(114) and Acanthamoeba (184), as well as mammalian vascular endothelial cells (185), 
and developing neurons (186) extend filopodia. These are typically 1 – 10 µm long and 0.1 
– 0.3 µm in diameter, are made of a core of 10 – 30 parallel actin filaments  with a protein-
rich complex at their tip (183, 187, 188). Modified forms of filopodia such as dendritic 
spines, cytonemes, and tunneling nanotubes promote intercellular communication during 
multicellular development (189–191). Defects in filopod formation alter cell spreading and 
adhesion (114, 115, 192), whereas overproduction of filopodia or filopodia-like protrusions 
is associated with increased invasiveness of metastatic cancer cells (193–195).   
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 Filopod elongation is triggered by small GTPase activity (142, 183)  and driven by 
the activity of actin elongation factors including VASP and formins, while the actin core 
is stabilized by actin cross-linking proteins (183).   A MyTH4-FERM (MF; myosin tail 
homology 4 - band 4.1, ezrin, radixin, moesin) myosin motor is also required.  A broad 
survey of genomes reveals that these essential filopodial proteins are evolutionarily 
conserved between Holozoa (a group that includes Metazoa and their closest single-cell 
relatives such as the choanoflagellate Monosiga brevicollis) as well as Amoebozoa (196).  
The existence of a shared, core filopodial machinery suggests that diverse organisms may 
employ fundamentally conserved means of generating filopodia.  
Organisms in a range of species have been reported to make filopodia or filopodia-like 
protrusions, but little is known about how these structures are generated by non-Metazoan 
eukaryotes (196). Amoebozoa share a common ancestor with animals and fungi (197), thus 
making Dictyostelium an excellent model system to test mechanistic conservation and 
diversity of these structures over evolutionary time (nearly a billion years of independent 
evolution).  Several proteins important for filopod formation in Metazoa are conserved 
with similar roles in Dictyostelium.  The widely conserved actin regulator VASP and the 
MF myosin DdMyo7 have critical roles in filopod initiation and the formin Dia2 is required 
for filopod elongation (114, 115, 131). While Dictyostelium lack the key Metazoan small 
GTPase Cdc42, the related GTPase Rac1a plays an analogous role in stimulating filopod 
formation (142).  Instead of the Metazoan actin cross-linking protein fascin (198) the actin 
binding proteins ABP-34 and EF-1α are believed to play a role in actin cross-linking in 
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Dictyostelium filopodia (199). The different actin cross-linking proteins used in 
Dictyostelium likely give rise to the less organized, shorter actin filaments in their filopodia 
(187).  Despite these differences, the abundance of structural and genetic similarities argues 
that filopod formation is a conserved cell biological process in Metazoa and Amoebozoa.   
Two different MF myosins have been found to be essential for filopodia formation in 
widely divergent organisms, Myo10 in vertebrates and DdMyo7 in the social amoeba 
Dictyostelium (112, 114). These two phylogenetically distant MF myosins have several 
features in common (Fig. 4B). They both have a number of light-chain binding sites (IQ 
motifs), an SAH domain (single α-helix) (200) and a C-terminal MF domain. Like several 
MF myosins, such as the Myo7 from humans or flies, DdMyo7 differs from Myo10 in 
having a second MF domain and an SH3 (src homology 3) domain inserted before the C-
terminal MF domain that is characteristic of this group of myosins. In contrast to DdMyo7, 
the tail of Myo10 (Fig. 4B) has PH (pleckstrin homology) domains in place of the internal 
MF and SH3 domains (201). Despite these differences in overall structure, the myo7 null 
Dictyostelium and HeLa or breast cancer cells with reduced Myo10 expression both exhibit 
a striking lack of filopodia (112, 114). The findings suggest that these two distinct MF 
myosins have functionally equivalent roles in filopod formation, one that has been 
conserved through almost a billion years of independent evolution. However, the 
phylogenetic relationship between Myo10 and DdMyo7 is unresolved and it is unclear how 
these two motors cooperate with their respective cohorts of filopodial proteins to build 
filopodia.  DdMyo7 has been classified as either a Myo7, a Myo22, a Myo25, or could not 
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be classified (28, 29, 114, 202) (see also cymobase.org). The uncertainty about the 
relationship between the Metazoan and Amoebozoan MF myosins and the differences in 
actin organization seen between Dictyostelium and mammalian filopodia raises the 
question whether Metazoan Myo10 and Amoebozoan DdMyo7 myosins contribute to 
filopod formation in a similar way, and whether their activities are conserved or specific to 
each organism.  In other words, do the filopodial MF myosins DdMyo7 and Myo10 possess 
convergent yet distinct functions in filopodia or do they share a conserved role in filopod 
formation despite their structural and phylogenetic differences? A functional dissection of 
the Dictyostelium MF myosin, DdMyo7, has been undertaken to begin to address this 
question.   
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2.3 Results 
    Deeper understanding of the role of DdMyo7 during filopod formation is needed to 
uncover functionally conserved and specific roles of MF myosins, particularly in 
comparison to Myo10’s role in filopod formation. Thus, a detailed characterization of 
DdMyo7 function in vivo was undertaken. A phylogenetic reassessment of MF myosins 
was also conducted to determine if the Amoebozoan Myo7s are indeed direct orthologs of 
any of the Metazoan MF myosins, or if they are a functionally distinct class of MF myosins 
that arose from a common ancestor.  
2.3.1 Phylogenetic Relationship Between DdMyo7 and Metazoan Myosins 
The evolutionary time (~600 million years; (203)) between Amoebozoa and Metazoa 
raises the question of how DdMyo7 differs from Metazoan Myo10 given their common 
role in filopod formation. The relationship between these MF myosins was unclear in 
previous studies of myosin diversity based on a comparison of motor domain sequences 
(29, 202) (see also cymobase.org). A phylogenetic analysis of the MF myosins using their 
defining feature, the C-terminal MyTH4-FERM domain, was thus conducted to better 
resolve their relationships. Full-length MF myosin sequences were gathered from 
representative organisms across all eukaryotes known to possess MF myosins. A total of 
162 sequences from 58 distinct species were used for this analysis, including the Metazoan 
MF myosins (Myo7, 10, 15, and 22), fungal and choanoflagellate Myo22, and the 
Amoebozoan MF myosins. Sequences for additional MF myosins including Myo32 were 
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gathered from the SAR clade (Stramenopiles, Alveolates and Rhizaria), a branch of 
unicellular eukaryotes which includes ciliates such as Tetrahymena and oomycetes such as 
the pathogenic water mold Phytophthora (85). Phylogenetic relationships between the 162 
C-terminal MF domain sequences were derived using SATé (204). 
The resulting phylogenetic tree (Fig. 4A) shows that the Amoebozoan MF myosins 
form a single family with two myosin classes. The Amoebozoan Myo7 (named for its 
structural resemblance to the animal Myo7) is found in social amoebae as well as solitary 
species such as Acanthamoeba. DdMyo7 (also known as MyoI) is the best-characterized 
example of this class. A second class of myosin present in social amoebae, Myo44 
(Dictyostelium MyoG), does not play a role in filopodia but has novel functions in 
chemotactic signaling (97). The Amoebozoan MF myosins are distinguished with high 
confidence from the Holozoan Myo7, Myo10 and Myo22 protein families and branch in a 
poorly defined region near the center of the tree, close to the presumptive root in the SAR 
group (Fig. 4A). The topology of the tree suggests that the common ancestor of these 
organisms contained a single MF myosin. Comparison of the domain organization of the 
myosins on each branch (Fig. 4B, C) reveals a common structure for the DdMyo7, Myo22, 
and Holozoan Myo7 proteins, each possessing a motor domain and tail region that contains 
three domains (two MF and one SH3 domains), but lacking PH domains. The tree suggests 
that the ancestral MF myosin underwent duplication after the emergence of the 
Amoebozoa, resulting in the proteins that established the Myo10/22 and Myo7/15 branches 
(Fig. 4A). The striking similarity in tail structure between DdMyo7, Myo22 and Myo7 
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suggests that these proteins have the ancestral tail structure. Amoebozoan MF myosins are 
exemplified by DdMyo7, which is structurally dissimilar to Myo10 yet similar in function, 
suggesting that core molecular features needed for filopod formation will be present in both 
DdMyo7 and Myo10. 
2.3.2 DdMyo7 is Present in Filopodia and Required for Their Formation 
Filopodia are a common feature of Dictyostelium cells from the vegetative phase 
through early development (114). Wild type Dictyostelium frequently display multiple 
filopodia (Fig. 5A), which appear as slender membrane projections that actively extend 
from the cell body close to the substrate, while myo7 null cells display virtually none (Fig. 
5A). Filopod formation was rescued by expression of full-length GFP-tagged DdMyo7 
(Fig. 6; referred to as DdMyo7 hereafter). Spinning disk confocal microscopy showed 
DdMyo7 localized to the actin cortex of an active leading edge (Fig. 5B), in filopodia tips, 
and in the cytosol, as previously reported (114, 161).  
Filopod initiation events were monitored in cells co-expressing DdMyo7 and RFP-
LifeAct to visualize actin filaments (122). DdMyo7 is present in the cytosol and in a typical 
initiation event, it was seen to become concentrated at the cortex (Fig. 5C). Then, a bright 
spot of myosin appeared, projecting from an actin-rich pseudopod. Filopodia elongated 
several micrometers within seven seconds, with actin present along the length and DdMyo7 
concentrated close to the filopod tip all throughout the elongation process (Fig. 5C). These 
results show that filopod initiation is a highly dynamic and rapid process. 
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Filopod formation activity was measured in a live cell assay by counting the number 
of filopodia per cell following 1 hour of starvation, a condition that consistently stimulates 
production of filopodia in wild type Dictyostelium. Arbitrary fields of view were selected 
for imaging by DIC and confocal GFP fluorescence. Blinded manual analysis demonstrated 
there is a low frequency of filopodia-like protrusions in myo7 null cells (Fig. 7; Table 5) 
and that expression of DdMyo7 rescues filopod formation. DdMyo7 fluorescence was 
distinctly observed at the tips of protrusions while GFP alone did not label protrusions (Fig. 
8). Thus, although DIC imaging could not resolve filopodia from other types of protrusions 
such as ruffles or retraction fibers, DdMyo7 localization at the tip identified the protrusions 
as filopodia. Automated image analysis was used to measure the number and length of 
filopodia (Fig. 5D). Filopod number in cells expressing DdMyo7 was not significantly 
different in wild type compared with rescued myo7 null cells (2.8 ± 0.4 filopodia/cell). The 
establishment of a quantitative assay for DdMyo7-based filopod formation allowed for an 
in-depth examination of the molecular requirements for this MF myosin in filopod 
formation. 
2.3.3 Complementary Roles of the DdMyo7 Head and Tail in Filopod Initiation 
The motor activity of Myo10 may be sufficient for filopod formation as expression of 
truncated dimeric Myo10 motors was reported to induce filopodia in mammalian cells 
(205). The question of whether the DdMyo7 motor domain is necessary or sufficient for 
filopod initiation was tested with a series of mutants. Expression plasmids encoding 
DdMyo7 mutant proteins were transformed into wild type cells as well as into myo7 null 
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cells (to assay their effect on filopod formation). Transformants were screened for GFP 
fluorescence and expression was confirmed by western blot (Fig. 6). The role of the motor 
domain was tested with two tailless mutants encompassing the motor domain and a putative 
lever arm region consisting of 4 light-chain binding IQ motifs, SAH (single α-helix), and 
an uncharacterized sequence potentially extending the lever arm (“motor-SAH”; aa 1-
1020) or this region plus the first proline-rich region (“motor-Pro1”; aa 1-1115) (Fig. 9A). 
Tailless mutants displayed diffuse cytosolic localization in both wild type and myo7 null 
cells (Fig. 9A, B), did not associate with pseudopodia, and did not rescue filopod formation 
in myo7 null cells. The longer motor-Pro1, in contrast to motor-SAH, did localize to filopod 
tips in wild type cells, suggesting that the Pro1 region may aid motor processivity necessary 
for DdMyo7 to reach filopod tips. A headless mutant comprised of the SAH and the full 
tail region was strongly enriched in pseudopodia of both wild type and myo7 null cells, yet 
failed to rescue filopodia in myo7 null cells (Fig. 9C). Localization of the headless mutant 
to filopod tips was variable in WT cells with DdMyo7 Tail either not reaching the tip (Fig. 
9C) or being weakly enriched there (Fig. 10B).  These observations establish that the tail 
region is required for localization of DdMyo7 to the cortical region, possibly through 
binding to a cortical or membrane associated partner, and that the motor domain is required 
to target DdMyo7 to filopod tips and/or retain DdMyo7 at the tip of an elongating filopod. 
Thus, both the motor and tail are required for filopod formation.  
2.3.4 Functional Redundancy of DdMyo7 FERM Domains 
The role of the dual MF domains in DdMyo7 was examined by analysis of the tail 
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region of this myosin. The MF domains form a compact supramodule and in the case of 
mammalian Myo7A MF1, the SH3 domain is coupled to the FERM domain (102, 206). 
FERM domains interact with MF myosin cargo proteins, including adhesion and signaling 
receptors, and can also mediate autoinhibition of the motor (201). Therefore, removal of 
an MF domain was predicted to affect DdMyo7 function. As with the headless and tailless 
mutants, DdMyo7 deletion mutants (Fig. 11A) were expressed in either wild type or myo7 
null cells. The number of filopodia per cell, their length, and elongation velocity were 
measured for those mutants that generate filopodia to determine which aspect of filopod 
formation was altered due to domain deletion. 
The contribution of the internal MF domain was examined with a DdMyo7 ∆MF1-
SH3 mutant that is stably expressed and rescues filopod formation in myo7 null cells (Fig. 
11A; Fig. 6). The ∆MF1-SH3 mutant localizes to both the leading edge and the tips of 
extending filopodia in wild type and myo7 null cells (Fig. 11A, B). Wild type or myo7 null 
cells expressing either the ∆MF1-SH3 mutant or full-length DdMyo7 produce similar 
numbers of filopodia (Fig. 12;  
Table 6) although the average length of filopodia in myo7 null cells expressing ∆MF1-
SH3 was reduced by 20% (Fig. 13;  
Table 6). Smaller deletions encompassing only the MF1 or FERM1 domains (∆MF1 
and ∆FERM1(f1, f2)) also did not affect the ability of DdMyo7 to promote filopod 
formation (Fig. 14).  Similarly, a deletion mutant targeting MF2 also rescued filopod 
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formation in myo7 null cells (Fig. 14). Thus, the MF domains appear to function 
redundantly with a single MF domain, either MF1 or MF2, being essential for the filopod 
formation activity of this myosin. 
Loss of filopodia is correlated with reduction in cell substrate adhesion in the myo7 
null cells as well in HeLa cells that have reduced levels of Myo10 (112, 114). The ability 
of the DdMyo7 FERM deletion mutants to rescue the myo7 null adhesion phenotype was 
assessed in polarized migrating cells by interference reflection microscopy (IRM) (207). 
Null cells expressing DdMyo7 exhibited improved adhesion to the substrate identical to 
wild type control cells, while the ∆MF1-SH3, ∆FERM2, and KKAA (see below) mutants 
also showed evidence of rescued adhesion (Fig. 15; Fig. 16). While there is a slight 
reduction of adhesion measured for the DdMyo7 mutants compared to the wild type rescue, 
the differences are not significant. These results are consistent with the finding that the two 
MF domains are functionally redundant. 
2.3.4 DdMyo7 FERM2 Domain Regulates Filopod Formation and Elongation 
MF myosins have been shown to be autoinhibited, with the C-terminal MF domain 
serving to regulate the in vitro and in vivo activities of fly and human Myo7A as well as 
mammalian Myo10 (208–211). In Myo10, PH domains and the FERM domain are required 
for autoinhibition that is relieved by phospholipid binding to PH domains (210). In Myo7A, 
a basic motif (K/RxxK/R) in FERM2 is critical for autoinhibition (208, 211), consistent 
with an intramolecular head-tail interaction. This regulatory basic motif is highly 
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conserved in Holozoan Myo7 and Myo22 and is also present in DdMyo7 (Fig. 11C), 
suggesting that DdMyo7 may also be subject to autoinhibition.  
The potential role of the DdMyo7 C-terminal FERM domain in controlling in vivo 
filopod formation activity was tested with two mutants of DdMyo7. The first mutant, 
∆FERM2, deleted the C-terminal FERM domain implicated in regulation of Myo7A and 
Myo10 and interaction with signaling and adhesion receptors (209, 210). The second 
mutant, KKAA, targeted two highly conserved basic residues in the FERM2 domain (Fig. 
11C) implicated in autoinhibition of Drosophila and human Myo7A (208, 211). The GFP-
tagged mutant DdMyo7 proteins were expressed in cells (Fig. 6) and analyzed by confocal 
microscopy. Both mutants localized to filopodia tips in wild type cells and rescued filopod 
formation in myo7 null cells (Fig. 11A) with characteristic leading edge concentration 
preceding filopod elongation (Fig. 11B). In the rescued cells, the DdMyo7 protein was 
highly concentrated at the tip and on average uniformly distributed along the shaft of the 
filopod, though less abundant (about 20% relative to fluorescence at the tip) (Fig. 10C, D). 
Wild type and mutant DdMyo7 appeared locally enriched at the cortical actin/membrane 
interface visualized by the membrane stain FM 4-64 (Fig. 8), consistent with a subcellular 
fractionation study of DdMyo7 (164). Furthermore, cortical enrichment at nascent filopod 
tips during initiation appears similar among ∆FERM2 and KKAA mutants and the wild 
type DdMyo7. 
Quantification of filopodia formation in wild type cells expressing the DdMyo7 
ΔFERM2 mutant showed that the number of filopodia formed was not significantly 
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different than full-length DdMyo7 when expressed in wild type cells (Fig. 12;  
Table 6). However, filopod number was increased by 35% (p = .04) in myo7 null cells 
expressing DdMyo7 ΔFERM2 (3.8 ± 0.4 filopodia/cell), suggesting that the FERM2 
domain negatively regulates filopod formation.  
Expression of the DdMyo7 KKAA mutant resulted in a large increase in the number 
of filopodia formed per cell in either wild type or myo7 null cells, which had 4.4 ± 0.6 and 
4.8 ± 0.3 filopodia/cell respectively (Fig. 12;  
Table 6). Overall, the KKAA mutant significantly increased filopod number by 66% 
with respect to full-length DdMyo7 (p = .00008) and 36% with respect to the ∆FERM2 
mutant (p = .003) with similar results for both WT and KO cells ( 
Table 6). The KKAA mutant exhibited localization similar to the wild type DdMyo7 
(Fig. 11A), suggesting that the conserved basic motif is not essential for activation or 
recruitment of DdMyo7 at the membrane. These data are consistent with inhibition of 
DdMyo7 motor activity by the FERM2 domain whereas relief of autoinhibition in the 
KKAA and ∆FERM2 mutants results in increased filopod formation activity. The increased 
activity of the KKAA mutant compared with ∆FERM2 and ∆MF1-SH3 mutants may 
indicate that both MF domains are needed for maximal filopod formation activity. The 
membrane recruitment of DdMyo7 likely depends upon additional, as yet unknown factors. 
Overexpression of Myo10 in mammalian endothelial cells increases both filopod 
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length as well as number (212) and it has been proposed that the Myo10 dimer plays a role 
in filopod initiation as well as elongation (201). To test whether the tail domains of 
DdMyo7 regulate filopod elongation, filopod length was measured in cells expressing 
DdMyo7 as described above (Fig. 5D). The average filopod length for wild type cells 
expressing DdMyo7 was 2.6 ± 0.3 µm, similar to the length observed for myo7 null cells 
expressing the same protein, 2.9 ± 0.2 µm (Fig. 13). The average filopod length did not 
differ significantly between WT or myo7 null cells expressing full-length DdMyo7 and 
those expressing ΔFERM2 or KKAA mutants ( 
Table 6). Time-lapse kymograph analysis was performed to further characterize 
filopod elongation in cells expressing these mutant DdMyo7 proteins. Filopod elongation 
events were analyzed using DdMyo7 fluorescence at the filopod tip to determine 
elongation velocity (Fig. 17). A nearly constant slope was found in the kymographs (Fig. 
17B), allowing the velocity to be measured with linear regression. The average velocity for 
myo7 null cells expressing DdMyo7 was 0.40 ± 0.03 μm s-1 (Fig. 17C;  
Table 6) and was not significantly altered in the ΔMF1-SH3 or KKAA mutants. 
Moreover, no apparent difference in filopod length was measured after expression of the 
KKAA mutant compared to DdMyo7 despite the observed increase in filopod number (Fig. 
12B; Fig. 13B). In contrast, the velocity of filopod elongation in cells expressing the 
ΔFERM2 mutant decreased 28% relative to DdMyo7 to 0.28 ± 0.01 μm s-1. The decrease 
in elongation velocity was significant compared to full-length DdMyo7 (p = .002; Tukey 
test). Taken together, these data support a role for the DdMyo7 FERM2 domain in 
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promoting filopod elongation in a manner that is independent of the KKAA motif.  
2.3.5 A Minimal Filopod Motor 
The expression of a minimal DdMyo7 motor region (motor-Pro1) produces virtually 
no filopodia in myo7 null cells, despite being localized at filopod tips in wild type cells 
(Fig. 9B; Fig. 7; Table 5). Thus, the motor-Pro1 was augmented with a MyTH4-FERM or 
MyTH4 domain added to the C-terminus (Fig. 18B). Initial attempts to express a motor-
Pro1-MF1 protein were unsuccessful, perhaps due to disruption of the MF1-SH3 
supramodule (206). Instead, a motor-Pro1-MF1-SH3 protein (i.e., GFP-DdMyo7 truncated 
at the C-terminus of the SH3 domain) was expressed in myo7 null cells (Fig. 18B; Fig. 6C). 
Filopodia were observed in GFP-positive cells with characteristic tip localization of the 
GFP fusion protein. Filopod length was comparable to that seen for DdMyo7 (Fig. 18C;  
Table 6) with an average of 2.8 ± 0.6 filopodia per cell observed during time lapse 
imaging. A fusion protein encoding motor-Pro1-MF2, with the MF2 domain taking the 
place of MF1-SH3, was tested with similar results (Fig. 18C). The large number of 
filopodia observed upon expression of motor-Pro1-MF1-SH3 and motor-Pro1-MF2 in 
myo7 null cells suggests that both the SH3 and the second proline-rich domain (aa 1685-
1830, Fig. 18A) are dispensable in filopod formation, while at least one MF domain is 
required.  
The ability to rescue filopod initiation conferred by the single MF motors strongly 
implies that the MF domain plays roles in targeting of the DdMyo7 motor to the cortex and 
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in the initiation of filopodia. The requirement for a FERM domain was further tested with 
motor-Pro1-MyTH4a protein, where the tail contains solely the internal MyTH4 domain. 
Filopod formation was rescued by motor-Pro1-MyTH4a despite the lack of a FERM 
domain (Fig. 18B). However, the number of filopodia was notably reduced compared to 
motor-Pro1-MF2 (Fig. 18D) while the average filopod length (Fig. 18C; Table 7) was again 
similar to the DdMyo7 rescue. While myosin motor activity is critical for filopod initiation, 
the ability of motor-Pro1-MyTH4a to promote filopod formation could be explained by 
interactions of MyTH4a with yet unidentified target proteins and/or conformational 
stability provided by the globular MyTH4 domain, favoring recruitment, clustering of 
myosin motors or dimerization of the extended lever arm and post-lever arm region (213). 
Substitution of mCherry for MyTH4a did not support filopod formation (Fig. 18E), 
demonstrating that the mere presence of a globular domain (mCherry) at the C-terminus is 
not sufficient for the assembly or recruitment of an active motor to promote filopodia at 
the plasma membrane. This analysis of DdMyo7 establishes that the minimal elements 
required for filopodial activity are a motor domain, lever arm, and a MyTH4 domain. The 
supramodular MyTH4-FERM domain confers optimal function to the myosin, likely by 
allowing it to interact with partners that promote growth of filopodia.  
2.3.6 Functional Conservation of MF Domains Across Kingdoms 
MyTH4-FERM myosins are required for filopod formation in humans (112) and 
amoebae (114). The strong morphological and genetic parallels between these distantly 
related proteins suggest that divergent MF myosins have conserved roles in filopodia 
 43 
formation.  Several attempts to express GFP-tagged bovine Myo10 (212) in Dictyostelium 
to test this possibility were unsuccessful, most likely due to the difficulty of cross-kingdom 
gene expression.  However, the identification of MF2 as a minimal tail domain supporting 
robust filopod formation raised the question of whether the common MF domain from the 
evolutionarily distant Myo10 might be able to functionally substitute for the DdMyo7 MF 
domain.  This possibility was tested using a DdMyo7 motor-Pro1-HsMyo10 MF domain 
chimera (Fig. 18B) that localized to filopodia in wild type cells (Fig. 19).  The Myo10MF 
chimera rescued filopodia formation in myo7 null cells, averaging 2.2 ± 0.2 filopodia per 
cell (Fig. 18D; Table 8).  However, the extent of rescue was less than with motor-Pro1-
MF2 (4.0 ± 0.1), but was comparable to the motor-Pro1-MyTH4a (1.8 ± 0.2 filopodia per 
cell).   A chimeric protein with a Myo10 MyTH4 tail (motor-Pro1-HsMyo10MyTH4) 
localized to filopodia in wild type cells (Fig. 19), but did not stimulate filopodia formation 
(Fig. 18D; Table 8).  These results reveal that there is functional conservation between 
filopodial MF domains, most likely due to shared features of the FERM domains of the 
human Myo10 and DdMyo7 MF domains.   
     Only a subset of MF myosins have a role in filopodia formation.  Others such as 
HsMyo7A and HsMyo7B function as transporters and anchors in stereocilia and microvilli, 
respectively (64, 208, 214), raising the question of whether there are features specific to 
filopodial MF domains or if an MF domain from a non-filopodial myosin can also 
functionally substitute for the DdMyo7 MF domain.  Dictyostelium expresses a second MF 
myosin with two MF domains, Myo44 (MyoG), that is essential for chemotactic signaling 
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but not required for filopodia formation (97).  The MF2 domain of Myo44 was fused to 
DdMyo7 motor-Pro1 and the resulting chimera expressed in wild type and myo7 null cells.  
Interestingly, the motor-Pro1-Myo44MF2 chimera expressed in myo7 null cells failed to 
rescue the filopodia defect (Table 8) and only weakly localized to filopodia in wild type 
cells (Fig. 19), revealing that there are intrinsic, conserved features of the filopodial MF 
domain required for its role in filopodia formation. 
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2.4 Discussion 
 Filopodia or filopodia-like protrusions are produced by a range of cell types in a 
diverse array of eukaryotic organisms, raising the question of whether these protrusions are 
formed by a core conserved mechanism or the emergence of independent pathways 
throughout phylogeny created multiple mechanisms of formation (196). Comparison of 
filopodia formation in Metazoa and Amoebozoa, groups that have been evolving 
independently for hundreds of millions of years (203), reveals that filopodia formation  
requires the same shared core set of filopodial proteins in these two branches of the 
phylogenetic tree. Specifically, several mammalian proteins essential for filopod formation 
either have direct orthologs (VASP (115) and Dia2 (131)) or functional homologs in 
Dictyostelium (e.g., Rac1a (142)); furthermore, mammalian cells and Dictyostelium both 
absolutely require the activity of a specialized MyTH4-FERM myosin (112, 114). Analysis 
of a series of DdMyo7 mutants and chimeras reveals that the important features of the 
DdMyo7 and Myo10 required for filopod formation are evolutionarily conserved. The 
results indicate that a functional filopodial MF myosin in Metazoa and Amoebozoa consists 
of its motor domain, an extended lever arm and short post-lever arm region that may be 
involved in dimerization, and an MF domain (Fig. 18).  
2.4.1 Evolution of MF myosins 
The MF myosin responsible for filopod formation in vertebrates, Myo10, is 
phylogenetically distinct from the Dictyostelium MF myosin DdMyo7 (Fig. 4). Attempts 
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to classify DdMyo7 in relation to other myosin motor domain sequences have yielded 
conflicting results (29, 202). The new molecular phylogenetic analysis focusing on the 
common MF domain (Fig. 4) reveals that Amoebozoan MF myosins are an evolutionarily 
distinct class of motor proteins.  DdMyo7 fails to group with the animal MF myosin classes, 
most likely because the gene duplications that produced these proteins occurred after the 
split between the Amoebozoa and Holozoa, over 600 million years ago (203). The analysis 
suggests that the common ancestor of Amoebozoa, Fungi, and Holozoa contained a myosin 
that had two MF domains and a tail structure similar to that of DdMyo7. These myosins 
share many structural similarities (Fig. 4B), including a highly conserved basic motif at the 
C-terminus of Myo7, Myo22 and Amoebozoan Myo7 (Fig. 11C) essential for 
autoinhibition of Drosophila and human Myo7A (208, 211) and regulation of DdMyo7 
activity (Fig. 12). These findings are consistent with DdMyo7 retaining core structural 
features of the last common ancestral MF myosin.  
MF myosins play critical roles in the formation and organization of protrusions 
containing parallel actin bundles such as filopodia (64, 112, 114), microvilli (214), and 
stereocilia (215, 216). These myosins may plausibly be seen as conserving a core ancestral 
function (196). However, the origins of this functional conservation are unclear. Although 
it is commonly assumed that gene duplications lead to novel functions (i.e., duplicated 
genes are maintained because one evolves a new adaptive function), a more frequent 
outcome is that gene duplications lead to partitioning of ancestral functions between the 
duplicated genes (217, 218). This logic implies that the functions of the ancestral protein 
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have been partitioned among the various MF myosin classes in Metazoa, such as filopodial 
versus non-filopodial myosins. Amoebozoan MF myosins, exemplified by DdMyo7, 
represent a branch preceding the expansion of Holozoan MF myosins on the Myo7/15 and 
Myo10/22 branches (Fig. 4A). In this view DdMyo7 is not an ortholog of any single animal 
MF myosin, but potentially is a model for all animal MF myosins. 
2.4.2 Basic requirements for MF myosin-based regulation of filopod formation. 
Filopod formation in both animals and amoebae requires myosin motor activity as well 
as the MF tail (Fig. 9; (112)). A DdMyo7 motor-lever arm mutant lacking domains 
following the SAH fails to localize to filopod tips in wild type Dictyostelium (Fig. 9A), 
paralleling results with a Myo10 missing the tail region following the SAH domain that is 
also not observed in filopodia tips in COS7 cells (205). A longer DdMyo7 protein including 
a proline-rich domain (motor-Pro1; corresponding to ∆MF1-SH3-Pro2-MF2) localized to 
filopod tips in wild type without rescuing filopod formation in myo7 null cells (Fig. 9B), 
again similar to results in COS7 cells where Myo10 ∆PH-MF or ∆MF mutants properly 
localized to basal filopodia yet failed to promote formation of dorsal filopodia (112). These 
results strongly imply that the ability of the motor to localize to filopodia is necessary but 
not sufficient for their formation. Although a tailless Myo10 was found to stimulate basal 
filopod formation in COS7 cells when long-lived Myo10 dimers were experimentally 
induced, these filopodia were short and unstable (205). The results seen with tailless 
DdMyo7 and Myo10 support the view that filopod initiation proceeds from mechanical re-
organization of actin filaments by dimeric MF myosin motors targeted to the cortex, with 
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elongation requiring both motor activity and the MF tail (either for cargo transport to the 
tip or to localize myosin activity to the tip). 
Functional analysis of the MF tail domain implicates the FERM2 domain in regulating 
DdMyo7 activity.   Deletion of the FERM2 domain results in increased numbers of 
filopodia that extend at a slower velocity (Figs. 4, 5 & 7).   Mutation of a conserved motif 
in FERM2 (KKAA) also leads to an increase in filopod formation (Fig. 12) but does not 
affect either filopod length or elongation velocity (Fig. 17; Fig. 13).  The observed increase 
in the activity of the KKAA mutant is reminiscent of what is observed for human Myo7A 
that is activated both in vitro and in vivo when the equivalent residues are mutated (208).   
Furthermore, while ectopic expression of Myo10 in COS7 cells increases filopod length, 
cells expressing a ∆FERM mutant produce shorter filopodia (212) that extend faster (219). 
This faster elongation likely results from the release of autoinhibition.  Together, these 
results could be explained in at least two ways.  FERM2 could interact with actin 
polymerization factors such as VASP or Dia2, or regulators of these proteins, to control 
the velocity of filopod elongation and loss of this domain thus leads to a slower elongation. 
It might also control myosin activity in vivo by autoinhibition of the motor, as has been 
seen for the Metazoan Myo7A and Myo10 (209–211).  This is consistent with a conserved 
mechanism of DdMyo7 activation by a binding partner, either in the cytosol as with 
Myo7A (220), or at the plasma membrane.    The contrasting effects of deleting the C-
terminal FERM domains of DdMyo7 and mammalian Myo10 on filopod length and 
elongation velocity may potentially be explained by differences in their binding partners 
 49 
or by the redundancy of DdMyo7 FERM domains as opposed to the single FERM domain 
of Myo10. Together, these findings support conserved roles for the C-terminal FERM 
domain regulating MF myosin activity as well as promoting the filopod formation activity 
of DdMyo7 and Myo10.  
2.4.2 Minimal and conserved features of MF myosin required for filopod formation. 
DdMyo7 proved surprisingly robust to domain deletion, as it was able to rescue filopod 
formation with either one of the MyTH4-FERM domains (Fig. 11).  The motor plus the 
post-lever arm region (motor-Pro1) itself is not sufficient to generate filopodia (Fig. 7; 
Table 5). However, addition of either the MF1-SH3 or MF2 domains to the motor imparted 
full functionality.  Consistent with this finding, Myo10 lacking the MF domain does not 
promote the formation of dorsal filopodia in COS7 cells (112). A minimal DdMyo7 motor 
fused to the MyTH4 domain alone can promote filopodia formation, but this activity is 
significantly augmented by the presence of the adjacent FERM domain (Fig. 18D;  Table 
8). The apparent congruence of Amoebozoan and Metazoan MF myosins suggested a 
chimeric approach to testing their relationship.  DdMyo7 motor-Pro1 fused to the human 
Myo10 MF domain (Fig. 18B-D) does rescue filopodia formation in the myo7 null mutant, 
albeit with reduced efficiency, with localization and filopod length comparable to native 
DdMyo7 (Fig. 18; Table 7; Table 8). This suggests that the Myo10 MF domain retains 
enough homology with DdMyo7 to function as a tail domain for filopod formation and that 
the MF domains of human and amoeboid filopodial myosins interact with conserved or 
analogous binding partners that mediate their role in stimulating filopod formation.  Failure 
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of the DdMyo7 motor-Pro1-Myo44 MF2 chimera to rescue filopodia formation establishes 
that MF domains are specific for the function of a particular MF myosin and that special 
features not found in Myo44 MF must be present in a MF domain for it to contribute to 
filopodia formation.  In contrast, Myo10 and DdMyo7 MF must have conserved such 
features, although it is unclear whether this involves the ability to recognize a common 
partner; Myo10 and DdMyo7 are not known to have any binding partners in common. The 
MF domain itself may be important for activation of the myosin or dimerization, possibly 
through interaction with a conserved partner that is yet to be identified.  The DdMyo7 
MyTH4a alone is sufficient to promote some filopodia forming activity, but not as robustly 
as the full MF, and the Myo10 MyTH4 alone cannot substitute for this domain (Fig. 18B-
D).   This may be due to loss of stability of the MF domain when the supramodule is 
disrupted by deletion of the FERM.  This supramodule is critical to coordinate how partners 
bind to the MF domain and the structures of the Myo10 and DdMyo7 MyTH4 (36, 56) 
establish how divergent their binding surfaces are, consistent with a lack of significant 
sequence conservation (only 24% identical and 40% similar). Thus, the absence of the 
FERM compromises the MyTH4 function and the Myo10 MyTH4 alone appears to be too 
divergent to even minimally substitute.  Future studies of specific surface mutations and 
their impact on the interaction with partners will be required to elucidate the role(s) of the 
MF supramodule in filopodia formation activity. 
2.4.3 Conclusions 
Evolutionarily distant MF myosins with essential roles in filopod formation have 
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several core features in common, indicating that their activity is not an example of 
convergent evolution but rather reveals a high degree of functional conservation between 
these motor proteins. The motor domains and post-lever arm regions of the Amoebozoan 
DdMyo7 and Metazoan Myo10 are essential for in vivo activity, and the tail domains play 
critical roles in the activity of these myosins. Filopod formation activity minimally requires 
a MyTH4-FERM supramodule specific to filopodial MF myosins that imparts optimal 
activity as well as regulation of filopod elongation (Fig. 18); however, the exact role of the 
MF domain in filopod formation remains to be clarified.  FERM domains interact variously 
with membrane receptors, actin filaments and other binding partners (102) that may work 
in concert with filopodial MF myosins to promote formation of filopodia, but the specific 
interactions have not been identified.   Additionally, the exact contribution of the motor 
during the different stages of filopod formation, especially the initiation step, remains to 
be clarified. It appears that the length and flexibility of the lever arms is critical (205) but 
how the motor might organize actin at the cortex and/or support transport along cortical 
actin to promote filopod formation is still unclear. Another intriguing question is what 
specific features confer filopod formation activity on an MF myosin. While the Metazoan 
Myo7 and Dictyostelium Myo44 have all of the essential domains required for filopod 
formation, including a C-terminal MF domain, they do not support filopod formation (97, 
220). Future studies using Dictyostelium as an ancestral MF myosin model system will 
address these fundamental questions and provide further insight into the evolutionary 
conservation of MF myosin function.
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2.5 Methods 
Cell Culture 
Wild type Dictyostelium Ax2 cells and wild type control (G1-21) and myo7 null 
(HTD17-1) (2) Ax3 cells were grown at 21˚ C on bacteriological plastic plates in HL5 
glucose medium (ForMedium)  supplemented with 10 kU/mL penicillin G and 10 µg/mL 
streptomycin sulfate (Sigma). Null cells were periodically selected in 10 µg/mL blasticidin 
S (Calbiochem). Cells were transformed by electroporation then selected and maintained 
using 20 µg/mL G418 (for neomycin resistance) (Fisher Scientific) or 50 µg/mL 
hygromycin B (Gold Biotechnology).  
Plasmid Design and Expression 
An integrating expression plasmid for the N-terminal GFP-tagged DdMyo7 full-length 
myosin, pDTi74, and the extrachromosomal GFP-Myo7 and GFP-Myo7 Tail plasmids 
have been described previously (114, 164). Standard molecular biological methods were 
used to generate mutant expression plasmids in the integrating pDTi74 background. 
Enzymes were obtained from New England Biolabs and the sequences of all PCR-
generated DNAs were verified by sequencing (University of Minnesota Genomics Center). 
RFP-tagged Lifeact in pDM358 (122) was a gift from Hanna Brzeska (Laboratory of Cell 
Biology, NHLBI, NIH). 
Microscopy 
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Epifluorescence and IRM microscopy experiments were performed on a Zeiss 
Axiovert 200 equipped with a 63X Ph3 Plan Apo (NA 1.4) objective and Spot RT camera 
(SPOT Diagnostics). Confocal microscopy was performed with 63X and 100X Plan Apo 
oil immersion objectives (NA 1.4) on a Marianas Spinning Disk Confocal imaging system 
based on a Zeiss Axiovert equipped with a Yokogawa CSU-X1, a Photometrics Evolve 
512 EMCCD camera, a Photometrics HQ2 CCD camera, an ASI MS-2000 stage controller, 
and laser lines at 488 and 561 nm all controlled by SlideBook 6.0 software (Intelligent 
Imaging Innovations, Denver, CO). TIRF microscopy was performed on a Zeiss Axiovert 
equipped with Photometrics QuantEM 512SC EMCCD camera, 100X Plan Apo (NA 1.46) 
objective and laser lines at 488 and 561 nm controlled by ZEN2 Blue software (Carl Zeiss).  
Live Cell Imaging 
Cells were plated in 35 mm glass observation dishes (MatTek or BiopTechs) at a 
density of ~105 cm-2 and allowed to adhere for 10 minutes. Cells were rinsed twice in 
starvation buffer (SB) (16.8 mM sodium/potassium phosphate adjusted to pH 6.4) and 
placed in 1 - 2 ml of SB for imaging 45 – 75 min following the onset of starvation. Assays 
of vegetative cells used low fluorescence media (ForMedium) in place of SB. For IRM 
experiments, cells were rinsed in twice in starvation buffer and plated on bacteriological 
plastic at a density of 1.4 x 105 cm-2 overnight (12-15 hours) at 11 °C to induce polarization 
(122). Cells were then resuspended, plated in observation dishes at room temperature, and 
imaged by IRM from 10-30 min after plating. 
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Data Analysis 
Statistical analyses were performed in Origin 9.0 (for ANOVA with Tukey post-hoc 
tests) or SPSS Statistics version 20 (for multiple ANOVA with contrasts). Significance was 
accepted at the p < 0.05 level. 
Plasmid Design and Expression 
An integrating expression plasmid for the N-terminal GFP-tagged DdMyo7 full-length 
myosin, pDTi74, and the extrachromosomal GFP-Myo7 and GFP-Myo7 Tail plasmids, 
pDTi112 and pDTi35 have been described previously (114, 164). Standard molecular 
biological methods were used to generate mutant expression plasmids in the integrating 
pDTi74 background. Enzymes were obtained from New England Biolabs and the 
sequences of all PCR-generated DNAs were verified by sequencing (University of 
Minnesota Genomics Center). RFP-tagged Lifeact in pDM358 (122) was a gift from 
Hannah Brzeska (Laboratory of Cell Biology, NHLBI, NIH). The ∆FERM2 deletion 
mutant was created using PCR-based methods to delete the C-terminal coding sequence 
from the myoI gene (accession number L35321.2) encoding the FERM domain (nts 6551 - 
7453; ends at amino acid 2056).  The ∆MF1-SH3 deletion mutant (nts 3725 – 5434; amino 
acids 1115-1684) and Motor-Pro1-MF1-SH3 mutant (∆Pro2-MF2 deletion at nts 5453 – 
7453; ends at amino acid 1690) were generated similarly. The KKAA mutant (K2333A, 
K2336A) was generated using the Q5 mutagenesis kit (New England Biolabs) to change 
the corresponding codons to GCA.  DdMyo7 motor-SAH (amino acids 1 - 1020) was 
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generated using PCR to obtain a genomic clone encoding the 5′ region of the myoI gene 
(nts 49 - 3442) and ligating this to the extrachromsomal vector pTX-GFP (221). DdMyo7 
motor-Pro1 (amino acids 1-1115) was generated by PCR (nts 49 – 3727) followed by 
ligation into a pDXA-based GFP expression vector (222). Expression vectors for a motor-
SAH construct (aa 1-879) in pTX-GFP or pDXA were also tested, but protein expression 
was poor and declined over time in culture. For tail domain fusions, the motor-Pro1 
plasmid was digested with BstEII and XhoI yielding a linearized vector for Gibson 
assembly. The 5′ fragment from the BstEII site through aa 1115 was amplified by PCR 
(Fwd.: 5′-cattagaattagaaaattgg-GTTACCCAATCCGTCATAC-3′, Rev: 5′-tcgatcgg-
TGAAACAGTTGGTTGTGG-3′). For motor-Pro1-MyTH4a, the 5′ fragment through aa 
1316 was amplified (Rev: 5′-aatttttgttctaatgcatctcgagctagctta-
ACGATTCTCTTTAATTGATTCTAATTC-3′). For motor-Pro1-MF2, the 5′ fragment 
through aa 1115 was amplified (Rev: 5′-ggtgatga-TGAAACAGTTGGTTGTGG-3′) along 
with a fragment encoding MF2 (aa 1811-2357; Fwd: 5′-ccaactgtttca-
TCATCACCACCAAACTTTAG-3′, Rev: 5′-aatttttgttctaatgcatctcgagctagc-
TTATTGAGAAGAATAAAATTGATAAACTG-3′). The motor-Pro1-HsMyo10 
sequences were constructed as follows: the regions of the Myo10 gene (accession no. 
NP_036466) encoding either the MyTH4 (amino acids 1501-1699) or MF (amino acids 
1501-2058, omitting residues 1871-1906 as previously described (100), were amplified by 
PCR (Fwd.: 5′-actgtttca-CCGATCGACACCCCCACC-3′, MyTH4 Rev:  Rev: 5′-
aatttttgttctaatgcatcgctagctta-TTCCTGCCTGTGGATCAGAG-3′; MF Rev:  5′-
aatttttgttctaatgcatc-GCTAGCTCACCTGGAGCTG-3′).  The linearized vector, 5′ DdMyo7 
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fragment and 3′ Myo10-MF or Myo10-MyTH4 tail fragment were assembled using HiFi 
Assembly Master Mix (NEB), transformed into E. coli, and verified by sequencing.  
DdMyo7 Motor-Pro1-Myo44 MF was generated in a similar fashion but instead the coding 
sequence for the DdMyo44 MF2 domain (aa 2906-3425) was amplified from a genomic 
clone (97);  (accession number XM_638108.1) as was a linker region encoding the Pro1 
region (Fwd: 5′-cattagaattagaaaattgg-GTTACCCAATCCGTCATAC-3′, Rev: 5′-ggttcacc-
TGAAACAGTTGGTTGTGG-3′; Fwd: 5′-actgtttca-GGTGAACCACAATTTTCTAC-3′, 
Rev: 5′-aatttttgttctaatgcatctcgagtt-ATCTCTTTTCTTTTTCTTTTCTTTCTC-3′) and these 
were then assembled in frame into an integrating plasmid containing DdMyo7 motor-Pro1 
coding sequence and verified by sequencing.  DdMyo7 Motor-Pro1-mCherry was 
generated in a similar fashion but amplifying the mCherry coding sequence as a 3′ tail 
fragment (Fwd.: 5′-actgtttca-ATGGTGAGCAAGGGCGAG-3′, Rev: 5′-
aatttttgttctaatgcatcgctagc-CTACTTGTACAGCTCGTCCATG-3′) and assembled in 
frame. The ∆FERM1 (nts 3734 - 5041; deleted for amino acids 1314 - 1553), ∆MF1 (nts 
3734 - 5230; deleted for amino acids 1118 - 1616) and ∆MF2 (nts 5903 - 7453; ends at 
amino acid 1840) deletion mutant integrating expression plasmids were generated using 
PCR. (114). The clone encoding bovine Myo10 was a gift from Richard E. Cheney (UNC 
– Chapel Hill).  The bovine Myo10 gene was amplified by PCR and cloned into the pTX-
GFP expression plasmid. 
Molecular Phylogenetics 
The majority of MF myosin heavy chain sequences were downloaded from 
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http://www.cymobase.org/, a database of cytoskeletal protein sequences (223) curated by 
Dr. Martin Kollmar and the CyMoBase team at the Max-Planck-Institute for Biophysical 
Chemistry (Göttingen, Germany).  Additional sequences were produced by the Joint 
Genome Institute (224) or the Physarum polycephalum Genome Resources server (225) 
(http://www.physarum-blast.ovgu.de).  A total of 162 sequences from 58 taxa were 
gathered and an initial alignment of these sequences was performed using MUSCLE (226).  
Only sequences with intact motor and MF domains were retained, to exclude incomplete 
or pseudogenic sequences. Domain boundaries were set using the nominal position of 
human Myo7A MF2 (residues 1749 – 2206).   When two MF domains were present only 
the C-terminal domain was used.  Simultaneous alignment and tree estimation (SATé II) 
was performed using MAFFT/MUSCLE and FastTree (204).   SATé performed an initial 
realignment followed by centroid decomposition and alignment using a WAG+gamma 
substitution model. Maximum subproblem size was set to 50% (81 sequences). 
Image Analysis 
Filopodia were imaged in the plane of contact between the cell and the coverslip where 
fluorescence of filopodia tips was greatest. The focal plane was located by DIC or by single 
frame confocal exposures. For counting assays, 3 - 6 planes were acquired at 63X 
magnification with a vertical step size of 0.3 µm repeated for 30 - 60 seconds. Assays of 
initiation and elongation used 100X magnification in 2 planes (1 µm step size) to increase 
the imaging rate. Automated image analysis generated a mask of the cell body and 
identified filopodia tips using GFP-DdMyo7 fluorescence. The use of DdMyo7 as a 
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filopodial marker was validated by blinded manual analysis of paired DIC and GFP images 
in which a single DIC image was acquired a few seconds prior to the start of GFP imaging 
(Fig. 7; Table 5). Membrane protrusions identified in DIC were strongly correlated in WT 
or rescue cells with GFP-DdMyo7 punctae at filopodia tips as previously reported (114, 
227). The number and length of filopodia (distance between the DdMyo7 puncta and cell 
periphery) were then measured (Fig. 5D). Two populations of cells were observed, those 
expressing DdMyo7 (showing cytosolic GFP fluorescence) and those not expressing the 
fusion protein (no fluorescence). An accurate count of cells expressing the protein but 
showing zero filopodia was not feasible with this method due to the difficulty in 
differentiating between cells not expressing or only weakly expressing DdMyo7. 
Consequently, filopod number was defined as the number of filopodia divided by number 
of cells with one or more filopodia (Fig. 5D). Filopodia number was determined by 
counting filopodia tips marked with GFP.  Briefly, regions corresponding to cell body were 
identified using a median filter and thresholding to create an image mask.  Two 
thresholding methods were tried in Fiji/ImageJ (228): full frame thresholding with 
moments and local thresholding with the Bernsen method (229). The former had reliable 
results for filopodia number but unreliable results for filopodia length based on small-scale 
manual analysis.  Local thresholding required manual correction of the mask file to remove 
fluorescent debris and autofluorescent cells with low GFP expression.  However, local 
thresholding produced reliable results for both number and length, so was used for all 
analyses.   
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Rescue of filopod formation by DdMyo7 mutants was classified in two categories: 
First, mutant proteins that produced numerous filopodia at near-wild type frequency were 
analyzed by automated counting of filopod tips in the first frame of fluorescence imaging. 
The second category included mutant proteins with minimal tail domains (MF1-SH3, MF2, 
M4a, HsMyo10MF, HsMyo10M4, Myo44MF2) that produced filopodia more rarely and 
required manual analysis. For automated counting, filopodia tips were identified using the 
Find Maxima function in ImageJ.  The radial intensity distribution around each candidate 
was analyzed in terms of the sample skewness ܩଵ (230).  Candidates with skewness less 
than 1 were considered fluorescent debris and discarded.  Remaining candidates were 
registered to the nearest cell center of area. Candidates >20 µm distant were discarded, 
while candidates >10 µm distant were manually reviewed for accuracy.  Both the total 
number of cells and number of filopodia registered to each cell were recorded. Because the 
proportion of cells with filopodia varied, filopodia number was defined as number of 
filopodia divided by number of cells with one or more filopodia.  Mutants with a low 
frequency of filopodia were manually reviewed to identify filopodia in each frame of the 
time lapse image stack (typically 10 – 30 s, no longer than 80 s). Image stacks were 
analyzed by an operator blinded to the identity of the DdMyo7 mutant protein in each 
image. Filopodia tips were identified as fluorescent puncta neighboring a GFP-positive cell 
that were observed in 2 or more frames and where the linear extent of the filopod was either 
clearly visible by GFP fluorescence, or not visible in the confocal section but inferred by 
the directed motion of the tip relative to the cell body. Regions of interest were acquired to 
indicate the locations of the filopodia identified by the first operator. For length analysis, a 
 60 
second operator manually reviewed the position of the ROI in relation to the tip and the 
threshold mask of the cell body. For filopod number analysis, only filopodia appearing 
within 10±1 s of the onset of GFP excitation were included to establish a uniform counting 
procedure for these low frequency events. 
Length of filopodia was estimated as the distance to the edge of the cell body on a line 
from the tip to the cell center. This estimate was validated by small-scale manual analysis.  
Kymographs and line scans were performed using manual tracing to define regions of 
interest. Filopod line scans used for fluorescence intensity analysis were aligned either 
automatically at the peak fluorescence intensity or, in the case of DdMyo7 tail, manually 
aligned at the distal ends of filopodia when tip enrichment was not observed. Kymographs 
used the maximum intensity from a 1.3 µm wide perpendicular region at each time point. 
The resulting image was processed with edge detection and thresholding to produce a plot 
of tip position where velocity was equal to the slope. Linear regression was performed 
(minimum of 5 pts, ≤ 0.8 s/pt, 133 nm pixel width) and an elongation velocity event was 
recorded using the regression slope of the longest segment where the squared correlation 
coefficient exceeded 0.98.  
IRM images were processed by correction for flat-field illumination (using the 
averaged image intensity for each assay followed by a 2 µm median filter) and thresholding 
as before using the same filter radius. Average contact area was calculated using the ImageJ 
“Analyze Particles” function with a circularity range of 0.10-1.0 to remove thresholding 
artifacts and a size range of 1-50 µm2 to exclude both small debris and cells with a large 
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contact area exclude non-migrating cells. 
Western blotting 
Expression of the DdMyo7 fusions was evaluated by western blotting (Fig. 6) using a 
mouse monoclonal anti-GFP antibody (MMS-118R, Covance Inc.) a rabbit polyclonal 
antibody specific for the DdMyo7 heavy chain (164), and the heavy chain of the class I 
myosin, MyoB, as a control (114, 161). Washed blots were incubated with Alexa Fluor 
680– or 800–conjugated goat anti-rabbit or goat anti-mouse secondary antibodies 
(Molecular Probes, Invitrogen).  Detection was performed using an Odyssey infrared 
imaging system (LI-COR Biosciences). 
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Table 5. Blinded Scoring of Filopodial Protrusions by GFP Fluorescence and DIC. 
GFP-Tagged Protein in KO 
Cells 
Total 
Cells  
No. GFP+ 
Cells 
Protrusions/ 
Cell (GFP) 
No. Protrusions 
(GFP) 
No. Protrusions 
(DIC) 
No. Protrusions 
(GFP) 
No. Protrusions 
(DIC) 
NONE 128 - - - 15 - 6.3% 
RESCUE        
        DdMyo7 113 83 1.51 125 116 51.8% 48.2% 
        ∆MF1-SH3 137 82 1.27 104 86 43.9% 36.3% 
        ∆FERM2 82 39 1.33 52 52 35.9% 35.9% 
        KKAA 81 32 5.03 161 91 81.3% 62.5% 
NO RESCUE        
        Motor-SAH 138 74 0.03 2 1 2.7% 1.4% 
        Motor-Pro1 266 126 0.01 1 11 0.8% 2.4% 
        Tail 1028 58 0.00 0 0 0.0% 0.0% 
CHIMERAS        
        Motor-Pro1-HsM10M4 691 400 0.05 18 15 3.5% 2.3% 
        Motor-Pro1-HsM10MF 542 255 0.09 22 71 5.9% 11.8% 
        Motor-Pro1-M44MF2 318 152 0.06 9 15 3.9% 4.6% 
   Paired DIC and GFP still images were manually scored for filopodia in several myo7 null cell lines expressing GFP-Myo7 fusions found to either rescue or 
not rescue filopod extension.  DIC images were first analyzed for cells extending slender projections and the number of projections per cell scored.  The 
corresponding fluorescence image was then analyzed for GFP-expressing cells and the number of GFP-tipped projections with a clear connection to the cell 
body was then counted for each cell.  Shown above are the values obtained for filopodia per cell for the GFP-expressing cells as observed both by DIC and 
fluorescence and the % of GFP-expressing cells that are observed to extend protrusions in DIC.  Note the strong correspondence between filopodia scored by 
GFP fluorescence and protrusions seen in DIC. 
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Table 6. Filopodia Number, Length and Elongation Velocity in DdMyo7-expressing Cells. 
Back-
ground 
Protein Filopod 
Number ± 
SEM* 
%Change 
[95% C.I.] 
p   Filopod 
Length ± 
SEM* (µm) 
%Change 
[95% C.I.] 
p Elongation 
Velocity ± SEM 
(n)** (µm/s) 
%Change 
[95% C.I.] 
p N 
WT DdMyo7 2.7 ± 0.3 - - 2.6 ± 0.3 - - n.d. - - 4 
∆MF1-SH3 3.1 ± 0.1 15% [-31, 
61%] 
.51 2.7 ± 0.2 5% [-21, 31%] .70 n.d. - - 4 
∆FERM2 2.9 ± 0.4 6% [-40, 
52%] 
.78 2.9 ± 0.2 12% [-13, 39%] .34 n.d. - - 4 
KKAA 4.4 ± 0.6 62% [16, 
108%] 
.01 2.8 ± 0.1 8% [-18, 35%] .52 n.d. - - 4 
KO DdMyo7 2.8 ± 0.4  - - 2.9 ± 0.2 - - 0.40 ± 0.03 (26) - - 6 
∆MF1-SH3 3.3 ± 0.3 17% [-20, 
53%] 
.36 2.3 ± 0.1 -20% [-2, -39%] .02 0.37 ± 0.02 (48) -7% [-28, 
13%] 
.77 6 
∆FERM2 3.8 ± 0.4 35% [1, 
70%] 
.04 3.3 ± 0.2 14% [-4, 32%] .12 0.29 ± 0.01 (60) -28% [-48, -
8%] 
.002 8 
KKAA 4.8 ± 0.3 69% [31, 
108%] 
.0008 2.7 ± 0.2 -8% [-26, 11%] .41 0.38 ± 0.03 (31) -4% [-26, 
18%] 
.97 5 
The indicated proteins were expressed in WT or KO Dicty cells and filopodia parameters were assayed. C.I. = confidence interval; SEM = standard error of 
the mean; %Change is relative to DdMyo7 in the same background (WT or KO). 
* SEM of N independent assays; ** SEM of n elongation events. 
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Table 7. Filopodia Length in Cells Expressing Minimal and Chimeric DdMyo7 Motors. 
Protein Filopod Length ± 
SEM (µm) 
n N p 
(Myo10MF) 
Motor-Pro1-MF1-SH3 2.5 ± 0.2 89 5 .83 
Motor-Pro1-MF2 3.1 ± 0.6 64 3 .12 
Motor-Pro1-MyTH4a 3.2 ± 0.4 47 4 .76 
Motor-Pro1-HsMyo10MF 3.6 ± 0.4 55 8 - 
Filopodia length in myo7 null Dicty cells expressing the indicated proteins. Mean of N independent 
assays is shown. SEM = standard error of the mean. *Multiple ANOVA of n filopodia (p = .34) 
contrasted with HsMyo10MF. 
 
Table 8. Filopodia Number in Cells Expressing Minimal and Chimeric DdMyo7 Motors. 
Protein Filopod 
Number ± 
SEM  
n  
(cells) 
N p 
(MyTH4a) * 
p 
(Myo10MF) * 
Motor-Pro1-MF1-SH3 2.8 ± 0.6 26 5 n.d. n.d. 
Motor-Pro1-MF2 4.0 ± 0.1 42 3 n.d. n.d. 
Motor-Pro1-MyTH4a 1.8 ± 0.2 38 5 - .27 
Motor-Pro1-HsMyo10MF 2.2 ± 0.2 18 7 .27 - 
Motor-Pro1-HsMyo10MyTH4 1.3 ± 0.1 50 9 .012 .0012 
Motor-Pro1-Myo44MF2 1.1 ± 0.1 10 4 .025 .0044 
Motor-Pro1 1.2 ± 0.1 18 4 .012 .0016 
Filopod number in myo7 null Dicty cells expressing the indicated proteins. Weighted mean of N 
independent assays is shown. SEM = standard error of the mean.  
*Multiple ANOVA of n cells (p = .001) with contrasts. n.d. = not determined. 
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2.7 Figures 
 
Fig. 4. Evolutionary relationships of MyTH4-FERM Myosins.  
(A) Phylogenetic analysis of MyTH4-FERM (MF) domains of myosins from representative organisms as 
determined by SATé (204). Likelihood values at major branch points (>95%) are indicated by circles, and 
the scale is as defined by FastTree (231).  
(B) Domain organization of DdMyo7 and Myo10, two MF myosins involved in filopod formation. See 
symbol legend at bottom for identification of domains. Domains of DdMyo7 include the Motor: myosin 
catalytic domain; IQ: light-chain binding motifs 1-4; SAH: single α-helix; Proline-rich regions; MyTH4: 
myosin tail homology 4; FERM: band 4.1, ezrin, radixin, moesin; and SH3: Src Homology 3. Myo10 contains 
three PH (Pleckstrin Homology) domains.  
(C) Domain organization of other major MF myosin families. 
 67 
                         
Fig. 5. DdMyo7 is present in filopodia from their initiation and at filopod tips during elongation. 
(A) DIC images of wild type (WT) and myo7 null cells (KO) illustrating the absence of filopodia in cells 
lacking DdMyo7. Scale 10 μm.  
(B) Filopod initiation in two KO cells expressing GFP-DdMyo7 over 10 s. The arrowheads point to 
emerging and extending filopodia that show the myosin concentrating near the distal tips. Scale 5 μm.  
(C) Time series showing formation of a filopodium at the edge of an actin-rich pseudopod in a myo7 null 
cell expressing GFP-DdMyo7 and RFP-LifeAct over time (seconds). Scale 4 μm.  
(D) Automated analysis of filopod number in maximum intensity projection confocal images. Shown is a 
representative cell expressing GFP-DdMyo7 (scale 10 μm). The cell body is masked (Mask) and filopod 
tips are located by GFP intensity before registering them to the cell (Analysis). Quantification of multiple 
images from either wild type (WT) or myo7 null cells (KO) expressing GFP-DdMyo7 yields an average of 
2.8 filopodia per cell, a baseline for further assays (see also  
Table 6).  
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Fig. 6.  Western analysis of GFP-DdMyo7 fusions. 
Western blotting of total cell lysates to validate expression of GFP fusions.   
(A) wild type and myo7 null lysates probed with anti-Myo7 antibody showing the presence of the ~270 kDa 
heavy chain in wild type cells (Ax2) that is missing from the myo7 null.   
(B) Wild type or (C) myo7 null cells expressing the DdMyo7 fusions analyzed probed with anti-GFP to detect 
the expressed heavy chain.  The position of the full-length GFP fusion is indicated (*).  All samples shown 
were also blotted for the 135 kDa MyoB (myosin 1B) heavy chain that is used as a loading control.  Note 
that lanes from several independent blots are shown.  
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Fig. 7. DIC Images of Dictyostelium cells under optimal conditions for filopodia 
formation.   
Randomly selected images of cells imaged by DIC microscopy illustrating scoring 
of filopodia for comparison with scoring by filopodial tip GFP fluorescence.  
Shown are the myo7 null cell line that does not extend filopodia, a non-rescued cell 
line (motor-Pro1) and two rescued lines (DdMyo7 and ∆FERM2).  Examples of 
filopodial extensions are indicated by arrowheads. Non-rescued cell lines show 
very rare protrusions compared to rescued cell lines (see also Table 5). Scale = 10 
µm.  
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Fig. 8. Filopodia visualized by GFP-DdMyo7 and fluorescent membrane marker FM 4-64.  
Dicty myo7 null cells (KO) expressing full-length and mutant DdMyo7 proteins, or GFP alone, were starved 
1 hour and incubated with 0.25 µg/ml FM 4-64 membrane dye for 1-5 minutes before confocal imaging. A 
single image plane is shown for the GFP (left) and red FM 4-64 (center) channels, the merge of the two 
channels is shown in the right. DdMyo7 is enriched in filopod tips and the filopodia are visible with FM 4-
64 as well as GFP staining along their length (yellow arrows). Note the cytosolic localization of GFP 
expressed in WT cells (top) contrasted with filopod tip localization of GFP-DdMyo7 in KO cells. 
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Fig. 9. The head and tail of DdMyo7 are required for filopod formation. 
(A) DdMyo7 motor-SAH does not localize to filopodia when expressed in wild type (WT) cells and does not 
rescue filopod formation in the myo7 null (KO) cells. Scale = 10 μm.  
(B) Motor-Pro1 localizes to filopodia in WT but does not rescue filopod formation in KO.  
(C) DdMyo7 Tail localizes to the cell leading edge in both WT and KO cells, and weakly localizes to filopodia 
in WT cells but does not rescue filopod formation in KO. Symbol legend with domain identification (same 
as in Fig. 4) below. 
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Fig. 10. Deletion or mutation of the C-terminal FERM2 domain does not alter the distribution of 
GFP-DdMyo7 along the length of the filopodium.  
Fluorescence intensity of GFP-DdMyo7 was measured using the peak intensity in filopodia tips to align 
filopodia on the x-axis (positive values are toward cell body) and localize DdMyo7 mutants in filopodia using 
the mean intensity along the length.  
(A) Shown at left is a representative WT cell expressing KKAA mutant protein (scale 10 μm). Images were 
processed by segmentation of the cell body (shown in center) followed by an intensity line scan when the 
filopod was near its maximum length.  Kymograph shown at right with time point used for the line scan 
outlined in yellow.  Scale is 4 μm × 10 s.   
(B) The tail expressed in wild type cells is occasionally seen to be localized to filopodia tips and along the 
length of the filopodium. Scale 10 μm.    
(C) Mean GFP intensity along the length of filopodia extended by myo7 null cells (KO) expressing full-
length DdMyo7, the C-terminal FERM2 deletion (∆FERM2), or point mutant (KKAA).  (D) Mean GFP 
intensity along the length of filopodia extended by wild type cells (WT) expressing full-length or mutant 
DdMyo7 or DdMyo7 tail.   Note that a small portion of DdMyo7 is located uniformly along the actin-rich 
shaft in cells expressing the wild type or deletion mutants.  In contrast, higher levels of the tail are observed 
along the shaft. The tail does not rescue filopod formation and is therefore not shown in KO. Peak value (x 
= 0) is normalized mean intensity of n filopodia (indicated for each condition). Shading indicates SEM of the 
number of filopodia averaged at each x value.  
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Fig. 11. Rescue of Filopod Formation by Mutant DdMyo7. 
(A) Domain organization of DdMyo7 mutants, with GFP fused to the N-termini, is shown (same legend as 
Fig. 4) with representative confocal fluorescence images of full-length DdMyo7, deletion mutants lacking 
the MF1-SH3 or C-terminal FERM2 domain, and a mutant with changes in conserved basic residues in the 
FERM2 domain (KKAA: K2333A, K2336A). The large panels show representative fields used in analysis 
of each DdMyo7 expressed in myo7 null cells. Scale 10 μm.  
(B) Detail of filopodia in extending pseudopods of KO cells expressing wild type and mutant DdMyo7 
proteins. Note the localization of DdMyo7 to leading edge and subsequently to filopod tips during elongation. 
Time lapse indicated in seconds; scale bar is 4 μm.  
(C) Sequence alignment showing a motif (K/RxxK/R) that is conserved in the FERM2 domain of MF 
myosins including DdMyo7, animal and choanoflagellate Myo7, and Myo22 but excluding Myo10. (arrows 
- conserved basic residues). Aea, Aedes aegyptii; Dd, Dictyostelium discoideum; Dm, Drosophila 
melanogaster; Hs, Homo sapiens; Mb, Monosiga brevicollis. Sequence positions are indicated on the left 
with conserved residues highlighted (blue = hydrophobic; red = basic; magenta = acidic; green = 
Asn/Thr/Ser; cyan = His/Tyr; orange = Gly; yellow = Pro).  
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Fig. 12. Filopod formation by 
DdMyo7 is regulated by the C-
terminal FERM2 domain. 
Filopodia were counted in 
Dictyostelium cells expressing 
DdMyo7.  
(A) Filopod number in cells expressing 
full-length DdMyo7, DdMyo7 with 
MF1-SH3 or FERM2 domain deletions 
(ΔMF1-SH3, ΔFERM2), and DdMyo7 
with double point mutation in the 
FERM2 domain (KKAA). Data shown 
for wild type (WT, open bars) and myo7 
null cells (KO, shaded bars). Number of 
GFP-positive cells n includes cells with 
and without filopodia.  
(B) Average filopod number per cell. 
Filopod number was defined as total 
filopodia divided by the number of cells 
with filopodia. Cells expressing the 
KKAA mutant (*) significantly 
increased filopod number by 66% 
compared with DdMyo7 (p = .00008), 
43% relative to ΔMF1-SH3 (p = .002), 
and 36% relative to ΔFERM2 (p = .003, 
multiple ANOVA with contrasts). 
Differences among other mutants were 
not significant (n.s.). Error bars are 
SEM; see  
Table 6. 
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Fig. 13. Filopodia length in myo7 null cells expressing DdMyo7 is 
decreased with deletion of the MF1-SH3, but not the FERM2 domain.   
Filopodia length was measured in cells expressing full-length or mutant 
(ΔMF1-SH3, ΔFERM2, KKAA) DdMyo7.  Average filopodia length is 
shown for (A) wild type (solid bars) and (B) myo7 null cells (shaded bars). 
Error bars are SEM; see also  
Table 6. 
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Fig. 14. Deletion of the MyTH4-FERM domains does not impair filopod formation by DdMyo7.   
DdMyo7 mutants expressed in myo7 null cells (KO) were imaged by confocal microscopy.   The 
domain organization of DdMyo7 mutants is shown on the left and fluorescence images on the right.   
(A) The ΔFERM1(f1, f2) mutant lacks the f1 and f2 subdomains of the internal FERM domain, but not 
f3 or the associated MyTH4 domain.  Additional deletions remove the  
(B) MF1 (located in the proximal tail region) or (C) MF2 (the common MF domain at the C-terminus).  
All mutants shown here localize to tips of filopodia and rescue filopod formation. Scale bar, 10 μm. 
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Fig. 15. Rescue of the myo7 null substrate 
adhesion defect in polarized cells.  
Cell-substrate contact area was measured by 
interference reflection microscopy (IRM).  
(A) Shown are IRM images of cell contact 
area for polarized myo7 null (KO) and wild 
type control cells. Scale 5 ࣆm.  
(B) Average contact area in myo7 null 
Dictyostelium is significantly decreased 
relative to WT control (**, p = .008) and 
DdMyo7 KO rescue (*, p = .01) cells. Error 
bars are SEM of N independent assays 
(shown). See also Fig. 16. 
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Fig. 16. Substrate adhesion in polarized myo7 null cells expressing DdMyo7 mutants.  
Cell-substrate contact area was imaged using interference reflection microscopy (IRM). Shown 
above are IRM images of cell contact area for myo7 null cells expressing full-length DdMyo7, 
∆MF1-SH3, ∆FERM2 and KKAA mutant proteins. Scale 5 μm. See also Fig. 15. 
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Fig. 17. Filopod elongation velocity is reduced by deletion of the FERM2 domain.  
(A) Histograms of elongation velocity during filopod formation events are shown for full-
length DdMyo7 and mutants (∆MF1-SH3, ΔFERM2, KKAA). Y-axis is percent of total.  
(B) Representative kymographs of filopod elongation in myo7 null cells expressing DdMyo7 
mutant proteins. Scale is 2 μm × 10 s.  
(C) Filopod elongation velocity is significantly decreased 28% in the ∆FERM2 mutant (*, p = 
.002) compared with full-length DdMyo7. The ΔMF1-SH3 and KKAA mutants do not differ 
significantly from full-length DdMyo7. Error bars are the SEM of the number of events n 
(shown; see also  
Table 6).  
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Fig. 18. Conservation of the requirement for a single MyTH4-FERM domain for MF myosin filopod 
forming activity.  
(A) Domain structure of DdMyo7 and human Myo10.  
(B) Representative images of cells with filopodia marked by the indicated fusion proteins. All mutants shown 
rescued filopod formation and strongly localized to filopod tips when expressed in myo7 null (KO) cells. 
Scale, 10 µm.  
(C) Histograms of filopod length in measured in KO cells expressing the indicated fusion proteins. Y-axis is 
percent of total (see also Table 8).  
(D) Filopod number in KO cells expressing the motor-Pro1 fused to the indicated tail domains. Filopod 
number was defined as total filopodia during 10 s time lapse observation divided by number of cells with 
filopodia. Weighted mean filopod number is shown with SEM of 3-9 independent experiments. Multiple 
ANOVA analysis (n = 10-50 cells) confirms significant increases in filopod formation for the MyTh4a (*, 
p<.05) and HsMyo10MF (**, p<.01) chimeras (see Table 8; MF1-SH3 and MF2 data excluded from ANOVA 
due to their much larger variance).  
(E) Domain structure of motor-Pro1-mCherry fusion protein and confocal fluorescence images showing 
merged GFP and mCherry channels (scale 10 μm). The expressed protein is cytosolic, lacks membrane 
enrichment and does not support filopod formation. 
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Fig. 19. Localization of DdMyo7 mutants with chimeric tail domains in wild type cells. 
DdMyo7 mutants expressed in wild type (WT) cells were imaged by confocal microscopy.   The domain 
organization of DdMyo7 mutants is shown on the left and fluorescence images on the right.   
(A) GFP-tagged motor-Pro1 is shown. Note localization at filopodia tips (arrows).  
(B) The equivalent proteins fused at the C-terminus with human Myo10 MyTH4 domain (HsMyo10M4), (C) 
human Myo10 MF domain (HsMyo10MF), or (D) Dictyostelium Myo44 MF2 domain. Scale, 10 µm. See 
also Fig. 18 and Table 8. 
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3 Biophysics of Myosin Function 
The motor function of myosin is determined by its structure, chemical kinetics, and 
thermodynamics. The mechanochemical cycle of myosin converts the binding energy of 
ATP into mechanical work through conformational change in the converter subdomain and 
light-chain binding (lever arm) domain. Conformational changes are coupled to the 
enzymatic cycle, with ATP hydrolysis making the cycle essentially irreversible: 
ATPସି + 2HଶO → HPOସଶି + ADPଷି + HଷOା 3-1 
Physiological studies are indispensable to decipher how molecular perturbations affect 
function at the cell, tissue or organism level, as demonstrated in the previous chapter. 
However, correct interpretation of physiological results requires carefully designed 
biophysical studies to understand the contribution of myosin at the molecular level. This 
chapter will briefly survey the field of myosin biophysics with a focus on fluorescence. 
Fluorescence spectroscopy methods are presented in Chapter 4, followed by a summary of 
progress toward in vivo myosin biosensors in Chapter 5. 
3.1 Historical Overview 
Striated muscles are highly ordered tissues that are ideally suited for anatomical or 
ultrastructural studies at every length scale, from low magnification optical microscopy to 
electron microscopy. Muscle has strong optical activity as a result of its linear ordering, 
providing high contrast in polarized light microscopy and birefringence measurements 
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(232, 233). It was appreciated as early as 1930 that the birefringence of actomyosin is a 
molecular property, not merely a consequence of muscle ultrastructure (234). The 
discovery of the ATPase activity of myosin by Engelhardt and others (235, 236) provided 
further evidence of mechanochemical coupling in muscle, and in 1944 it was found that 
addition of ATP to the actomyosin rigor complex induced myosin to dissociate from actin, 
increasing the observed birefringence consistent with the increased electric dipole moment 
of the bare actin filaments (237). This provided clear evidence that myosin enzymatic 
activity was coupled to actin binding. 
The first detailed studies of muscle ultrastructure were performed by Hugh Huxley 
(238). In 1957 Huxley used electron microscopy, combined with careful interpretation of 
thin cross-sections of muscle, to show that striated muscle contains linear paracrystalline 
arrays of actin and myosin filaments along with repeating units of other proteins present in 
the sarcomere. Huxley had observed that muscle fibers produced coherent diffraction 
patterns in small-angle X-ray scattering studies in the early 1950’s. Technical limitations 
hindered progress until 1967 when Huxley and Brown showed changes in the diffraction 
amplitude pattern correlated with formation of myosin-actin “cross-bridges” during muscle 
contraction (239).  
3.2 Crystallography and Cryo-Electron Microscopy 
Progress in understanding kinetics and mechanics of muscle myosin proceeded rapidly 
in the 1970’s and 1980’s yet structural progress was slow, albeit with advances in some 
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areas including proteolytic digestion and mapping with photoreactive nucleotide analogs. 
Myosin was first successfully crystallized by the Rayment group (240, 241). This structure 
showed nucleotide-free (i.e., post-powerstroke) skeletal myosin motor domain with a 
partially resolved light-chain binding domain. This was followed by a succession of 
Dictyostelium MhcA (DdMhcA) structures with a variety of nucleotide analogs mimicking 
intermediates in the mechanochemical cycle. However, for technical reasons, the 
Dictyostelium protein was truncated before the light-chain binding domain. The first clear 
picture of myosin in a pre-powerstroke conformation arrived from the Cohen group: 
smooth muscle myosin with bound ADP∙AlF4 (an ADP·Pi analog) showing a ‘bent’ light-
chain binding domain as predicted from mechanistic considerations (242). 
The first crystallographic structures of myosin with fully resolved light-chains were 
produced by the Cohen group1, showing scallop adductor muscle myosin in nucleotide-
free (post-powerstroke), ADP, and ADP∙VO4 (pre-powerstroke) states (243, 244). These 
structures set scallop myosin as a reference point for modeling the lever arm rotation of 
myosins such as DdMhcA. 
The actin-myosin complex has proven resistant to crystallization. Since the structural 
changes within myosin bound to actin are of great interest, the Holmes group made early 
attempts to model the complex with small-angle X-ray scattering data (245) and later with 
                                                 
1 To date the only fully resolved myosin + light chain crystal structures are those of the Cohen group. 
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cryo-EM data at 14Å resolution (246). The first medium-resolution cryo-EM structure was 
produced by the Raunser group showing Dictyostelium Myo1E bound to actin-tropomyosin 
filaments at 8Å (247)2. This was followed recently by the structure of human non-muscle 
myosin 2C bound to actin-tropomyosin at 3.9Å (248). A forthcoming structure from the 
Alushin and Bryant groups shows Myosin VI bound to actin at 4.5Å (249). A current trend 
that shows great promise is the combination of available crystal structures with new, high-
resolution cryo-EM structures to create a fully populated model of myosin’s 
mechanochemical cycle (250). 
While crystallography and electron microscopy have revealed myosin structures in 
atomic detail, including the structures of strongly-bound actin-myosin complexes, these 
methods share an inherent weakness: in computation of average structures, rare or short-
lived intermediate structures may be lost. Furthermore, both techniques are severely limited 
in their ability to report structural dynamics. A complete understanding of how the 
structural transitions of myosin are regulated requires methods that observe myosin during 
its mechanochemical cycle. This has been best achieved with fluorescence spectroscopy as 
detailed next.  
                                                 
2 An unnatural scenario since Dictyostelium lacks tropomyosin. 
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3.3 Fluorescence Spectroscopy 
Fluorescence methods have 
been applied to study myosin 
structure and kinetics in great 
depth (251). This section will 
focus on approaches to testing the 
correspondence of light-chain 
binding domain orientation and 
nucleotide state of the motor 
domain observed in static 
structures (5, 21). The light-chain 
binding domain is believed to 
rotate as a lever arm during the powerstroke (Fig. 20). A common approach to detecting 
this conformational change is to place a fluorescent donor probe on the motor domain and 
a fluorescent acceptor probe on the light-chain helix or light chains (Fig. 21). By choosing 
probes with overlapping donor emission and acceptor absorption spectra, and using site-
directed attachments to create a spatial resonance overlap of the donor and acceptor 
electronic dipoles, the change in distance can be measured using the Förster equation as 
loss of donor fluorescence and/or appearance of acceptor fluorescence (252). 
ADP∙Pi
Power 
stroke
ATP
bent
straight
ADP
ATP
Recovery 
stroke
hydrolysis
exchange
 
Fig. 20. Structural Transitions in Myosin. 
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In early example of this approach, 
the Sutoh group used truncated 
Dictyostelium MhcA motor domain 
expressed with N-terminal GFP and C-
terminal BFP tags  (253). The purified 
protein showed large FRET efficiency in 
the nucleotide-free (apo) state that 
decreased modestly with ADP and most 
strongly with ATP (relaxation). 
Although these results were promising, 
several challenges to reproducing and 
extending these results were identified 
(254), namely fluorescent protein 
photophysics, rotational dynamics, and 
photobleaching (photodepletion). These 
challenges arise in all fluorescent protein applications but will be examined using the 
example of the Sutoh study. 
First, photophysical changes occurred in GFP when it was in contact with BFP, leading 
to excited state proton transfer to the donor that decreased the calculated FRET efficiency 
to 44% from its true value of 70%. This showed that although fluorescent proteins are 
generally resistant to environmental effects on fluorescence, it is essential to control for 
 
Fig. 21. Förster Resonance Energy Transfer (FRET) 
(Top left) Energy levels of the donor molecule are shown: 
ground state (S0) and electronically excited state (S1). 
Following vibrational relaxation (~1012 s-1) the donor 
decays by fluorescence (~109 s-1) or resonance energy 
transfer to the acceptor ground state (top right). FRET 
occurs when the donor emission and acceptor absorption 
bands overlap (bottom panel) and the probes are separated 
from spatial overlap of electron orbitals (R > 2 nm) but 
close enough for resonance overlap proportional to R-6. 
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intermolecular interactions that may affect energy transfer.  
Second, rotational dynamics of fluorescent proteins (molecular weight ~ 26 kDa) are 
substantially slower (>10 ns) than the donor lifetime (2-5 ns) making the orientation of the 
donor and acceptor virtually static with respect to fluorescence. Thus it is necessary to 
model the restricted orientation distribution of the fluorescent protein (255–257) or 
establish that the orientation is isotropic (the best case scenario for current probes). The 
effect of the static isotropic distribution on calculated distance is easily corrected (258).  
Finally, early generations of fluorescent protein such as BFP and YFP were highly 
prone to photobleaching (irreversible loss of fluorescence due to bond breaking). Current 
fluorescent proteins are more stable, and experimental design minimizes these effects 
(259). 
Shih et al. took the approach of engineering a ‘Cys-lite’ version of DdMhcA, removing 
surface-reactive cysteine residues (260, 261). This permitted site-directed labeling with 
chemical dyes reactive with engineered surface cysteines. An Oregon Green donor was 
attached to the RLC and a tetramethylrhodamine acceptor was placed in the upper 
subdomain of the motor. Both dyes are environmentally insensitive, rotate rapidly due to 
their small size, and are relatively resistant to photobleaching; thus, the difficulties seen 
with fluorescent proteins were mostly avoided. The authors measured changes in the donor 
fluorescence lifetime using a frequency-domain method, but other methods are available 
such as time-domain lifetime measurement and spectral recording (Fig. 22). The average 
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FRET efficiency increased from 16% (apo) 
to 36% (ATP) and 61% (ADP∙VO4). Since 
vanadate ion is thought to stabilize a pre-
powerstroke conformation, the authors 
argued that the intermediate FRET value 
seen with ATP (relaxation) represented a 
mixture of pre- and post-powerstroke states. 
Despite the early success of Shih et al.’s 
approach, technical limitations in protein 
production made reproduction of their 
approach virtually prohibitive (262). A 
hybrid approach was taken by the Thomas 
group using a Cys-lite, truncated MhcA 
motor domain with site-directed labeling of 
the relay helix, an internal helix that 
communicates changes in the nucleotide 
binding site to the converter subdomain. 
Analysis based on crystal structures 
predicted the C-terminal end of the helix 
would move nearly 1.5 nm during the 
powerstroke, in a ‘bent-to-straight’ transition 
 
Fig. 22. Comparison of Fluorescence Emission 
Spectrum and Lifetime. (Top) Fluorescence spectra 
of GFP-MhcA (SD) and GFP-MhcA+RLC-RFP 
(SD+A) upon excitation of GFP; (Middle) Difference 
spectrum showing RFP sensitized emission; 
(Bottom) GFP donor or donor/acceptor (GFP/RFP) 
fluorescence lifetime measured by time-correlated 
single-photon counting (TCSPC). Instrument 
response function (IRF), black squares. 
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mirroring the straightening of the light-chain binding domain. Time-domain FRET studies 
confirmed this was the case, highlighting the role of phosphate release in gating the 
structural transition of myosin (263, 264) (20, 265). 
All the approaches mentioned focus on fluorescence spectroscopy of myosin in 
purified solutions. While this is an essential step in validation of any biosensor, few 
attempts have been made to study myosin lever arm rotation in living cells; in a notable 
exception, the Uyeda group used spectral recording to measure force-dependent spectral 
changes in GFP (266, 267), but the artificial design of this sensor (a tandem dimer) limits 
its applicability. 
Understanding myosin physiological function requires detailed knowledge of the 
spatial and temporal regulation leading to activation of myosin, as well as the effect of 
actin-myosin and myosin-cargo interactions on force generation, attachment and 
detachment. An ideal assay would measure both the biochemical and mechanical states of 
myosin in the cell, correlating the results to understand the mechanisms of regulation. 
3.4 Biochemical and Mechanical Assays 
Biochemical studies of myosin activity have long focused on kinetic measurements of 
ATPase activity (268), with maximum ATPase velocity ݒ଴ related to total cycle time by: 
ݒ଴஺்௉௔௦௘ =
1
ݐ௖௬௖௟௘
 3-2 
Mechanical activity of myosin can be measured using a method known as the unloaded 
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in vitro motility assay (unloaded because filaments in solution experience negligible drag). 
The assay measures the maximum velocity of actin filament translocation (269): 
ݒ଴
௠௢௧௜௟௜௧௬ =
݀
ݐ௦௧௥௢௡௚
 3-3 
Where d is the distance travelled by the lever arm during the powerstroke and ݐ௦௧௥௢௡௚ 
is the time that myosin is strongly bound to actin. The distance d may be directly measured 
using optical trapping techniques or calculated from ATPase and motility data: 
ݒ = ݒ଴
[ATP]
ܭ௠ + [ATP]
 3-4 
Duty Ratio ≝
ݐ௦௧௥௢௡௚
ݐ௖௬௖௟௘
=
ܭ௠஺்௉௔௦௘
ܭ௠
௠௢௧௜௟௜௧௬ 3-5 
݀ = ݒ଴
௠௢௧௜௟௜௧௬ ⋅ ݐ௦௧௥௢௡௚ = Duty Ratio ⋅
ݒ଴
௠௢௧௜௟௜௧௬
ݒ଴஺்௉௔௦௘
 3-6 
Where Eq. 3-4 is the Michaelis-Menten equation for ATPase activity in the presence 
of saturating F-actin. The duty ratio is the fraction of myosin that is strongly bound to actin 
in the presence of saturating ATP and is defined in kinetic terms in Eq. 3-5 (270)3. The 
powerstroke distance d is given in Eq. 3-6; note that calculation of ݐ௦௧௥௢௡௚ is implicit. 
More physiologically relevant quantities are the ensemble force and the power (272), 
                                                 
3 Duty ratio of some myosins may be measured by fluorescence quenching of pyrene-actin (271) 
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i.e., the mechanical work performed by myosin per unit time, defined as 
ܨ௘௡௦௘௠௕௟௘ = ௧ܰ௢௧௔௟ ⋅ Duty Ratio ⋅ ௜݂௡௧  = ௦ܰ௧௥௢௡௚ ⋅ ௜݂௡௧   3-7 
௜ܲ௡௧ = ௜݂௡௧ ⋅ ݒ(ܶ) 3-8 
௘ܲ௡௦௘௠௕௟௘ = ௦ܰ௧௥௢௡௚ ⋅ ௜݂௡௧ ⋅ ݒ(ܶ)    3-9 
Where ௜݂௡௧, the intrinsic force generated by myosin, is a molecular property related to 
the efficiency of the motor that is effectively constant (273–275). The velocity ݒ(ܶ) is 
highly sensitive to the local tension ܶ  applied to the cargo and/or the actin filament (6, 276) 
as well as the local concentrations of ATP and accessible binding sites on actin. This 
highlights the need to develop molecular tension sensors to detect the average local tension 
experienced by a myosin motor, a task that has not been convincingly attempted. The 
ensemble force (Eq. 3-7) does not require a molecular tension sensor as the force can be 
measured directly, without knowledge of the local velocity. Specifically, the ensemble 
force depends on the number of myosin molecules in the ensemble, ௧ܰ௢௧௔௟, and the fraction 
of strongly bound myosin molecules (the duty ratio). Since ௧ܰ௢௧௔௟ is readily estimated by 
imaging, design of cellular biosensors should focus on detection of the strongly-bound 
post-powerstroke state (duty ratio) to enable measurement of the myosin ensemble force. 
Measuring the duty ratio of myosin motors requires a technique that can resolve 
structural conformations within an ensemble, either in solution with purified proteins or in 
a cell. Time-resolved FRET provides an avenue to use spectroscopy to directly measure 
the duty ratio, and with it the ensemble force generated by myosin. As a preliminary step 
to development of myosin biosensors, rapid high-precision time-domain fluorescence 
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lifetime methods were developed as described in Chapter 4. Preliminary application to a 
myosin 2 biosensor expressed in Dictyostelium is reported in Chapter 5.
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4 Fluorescence Lifetime Plate Reader: 
Resolution and Precision Meet High-
Throughput1 
4.1 Chapter Summary   
We describe a nanosecond time-resolved fluorescence spectrometer that acquires 
fluorescence decay waveforms from each well of a 384-well microplate in 3 minutes with 
signal-to-noise exceeding 400 using direct waveform recording. The instrument combines 
high-energy pulsed laser sources (5-10 kHz repetition rate) with a photomultiplier and 
high-speed digitizer (1 GHz) to record a fluorescence decay waveform after each pulse. 
Waveforms acquired from rhodamine or EDANS dyes in a 384-well plate gave lifetime 
measurements 5- to 25-fold more precise than the simultaneous intensity measurements. 
Lifetimes as short as 0.04 ns were acquired by interleaving with an effective sample rate 
of 5 GHz. Lifetime measurements resolved mixtures of single-exponential dyes with better 
than 1% accuracy. The fluorescence lifetime plate reader enables multiple-well 
fluorescence lifetime measurements with an acquisition time of 0.5 s per well, suitable for 
                                                 
1 Reprinted from: Petersen KJ, Peterson KC, Muretta JM, Higgins SE, Gillispie GD, Thomas DD. 2014. 
Fluorescence lifetime plate reader: Resolution and precision meet high-throughput. Review of Scientific 
Instruments. 85(11):113101. PMCID: PMC4242087, with the permission of AIP Publishing. Copyright © 
2014 AIP Publishing, LLC. 
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high-throughput fluorescence lifetime screening applications. 
4.2 Introduction 
Fluorescence spectroscopy provides exceptional sensitivity for biological assays, 
because the fluorescence emission signal is readily separated from excitation and 
background fluorescence wavelengths, but its precision is limited by the inherent 
variability of fluorescence intensity (277, 278). Intensity-based measurements are subject 
to noise due to uncertainty in optical path length or assay volume, light scatter from 
surfaces or contaminating particulates, differences in local concentration of fluorophores, 
or presence of interfering fluorescent compounds (279). Nanosecond time-resolved 
fluorescence measurements provide a means to improve assay resolution and precision, 
because the time-resolved signal is largely independent of intensity variations (280). The 
fluorescence lifetime (an observable related to the quantum yield) may be used to analyze 
fluorescence decay waveforms by methods including moment analysis (281), multi-
exponential fitting (282, 283), or phasor analysis (284). Fluorescence lifetime detection is 
most useful in assays sensitive to probe environment, such as fluorescence quenching, 
resonance energy transfer, or intrinsic fluorescence (252). Lifetime-based assays have been 
used to measure macromolecular interactions (284, 285), distances (286, 20), and forces 
(287) as well as enzyme activity and ligand binding (288–290). 
High-precision lifetime measurements are typically performed with time-correlated 
single-photon counting (TCSPC) (291), a digital method that employs low-intensity 
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excitation at the expense of long acquisition times (typically seconds or longer to obtain 
signal-to-noise ≥ 100). The alternative method of direct waveform recording (DWR) 
acquires analog fluorescence decays in response to high-intensity pulsed excitation (292). 
DWR dramatically reduces acquisition time from ~10 s to ~0.1 ms, without sacrificing 
accuracy or precision, by exciting many probe molecules with a single pulse and detecting 
thousands of emitted photons (292). We have demonstrated that this technology enables 
the acquisition of hundreds of high signal-to-noise waveforms with nanosecond time 
resolution and kHz repetition rate following stopped-flow (20, 293). We have developed a 
new instrument to enable high-throughput sample preparation and detection in a 384-well 
microplate format. Here we present a description of the NovaFluor Plate Reader that has 
already been employed in high-throughput studies (294, 295). We show here that 
fluorescence lifetime measurement in this instrument dramatically improves measurement 
precision relative to fluorescence intensity, without sacrificing throughput, in addition to 
its benefits for signal resolution, in a fluorescence lifetime plate reader. 
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4.3 Materials and Methods 
4.3.1 Instrument 
 The NovaFluor plate reader (Fig. 23) was designed and built by Fluorescence 
Innovations, Inc. We performed 355 and 532 nm excitation with a 10-kHz pulse rate using 
an yttrium-aluminum-garnet microchip laser (JDS Uniphase) followed by a frequency 
multiplier and bandpass filter. We excited at 473 nm with a 5-kHz pulse rate using an FP2-
473-3-5 microchip laser with LD-702 controller (Concepts Research Corporation). 
Excitation light passed through a neutral density filter and then through a pinhole in a 
collector mirror fixed beneath the moving stage. Fluorescence was gathered by the 
parabolic mirror for detection. Emission filters (470/20 nm band pass or 590/10 nm band 
pass) were placed before the detector, a H10270-20 photomultiplier tube (Hamamatsu) 
operating at 400 V except as noted. Detector current was converted to voltage at 50 Ω by 
a custom circuit board based on a 1 GHz analog transient waveform digitizer (ATWD 
version 3.1) (296). Motors driving the X-Y stage, shutter, neutral density and emission 
filters were controlled by a second custom board. All controllers were routed to USB using 
an RS-232 serial adapter. Instrument control and data acquisition were performed with 
custom software on a personal computer. We used an Ophir PD-10v2 power meter to 
calibrate neutral density filter position. 
Solid dyes were dissolved to ~1 mM in spectroscopic grade ethanol and stored at -20 
°C, except EDANS (5-((2-aminoethyl) amino) naphthalene-1-sulfonic acid) which was 
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dissolved in N, N-dimethyl-formamide. Working solutions were diluted to 1 M (except 
as noted) in de-ionized water. Rhodamine B and 6G were excited at 473 nm, EDANS at 
355 nm, and Rose Bengal at 532 nm. Fluorescence decays were acquired (Fig. 24) using a 
neutral density filter to adjust the peak signal to near 100 mV with 50-150 mV as an optimal 
range (1-3 mA peak output current of the PMT). We recorded decay waveforms with 640 
samples at 0.2 ns resolution (128 ns total time). The signal delay was adjusted to allow at 
least 40 samples (8 ns) of pre-excitation data used to adjust the signal baseline. 
4.3.2 Microplate Preparation 
 We loaded plates manually with a multichannel pipet (ThermoFisher) or 
automatically with a FlexDrop IV dispenser (PerkinElmer). We used well volumes of 50 
or 100 L in a 384-well glass-bottomed Greiner SensoPlate. Dye mixtures were dispensed 
in volumes with 5 L increments. Plates were spun briefly (up to 300 rpm in Eppendorf 
rotor 5810R A-4-81) to remove air bubbles. The instrument response (IRF) was influenced 
by choice of laser, PMT voltage, and other factors and was acquired daily from a single 
well of de-ionized water with neutral density filter adjusted to a 100-mV peak signal. 
4.3.3 Data Analysis 
 Analysis of total fluorescence and first moment was performed in Microsoft Excel or 
Matlab (MathWorks). Total fluorescence was calculated as ∑ ܨ(ݐ௜)௜ , where ܨ(ݐ) was the 
signal intensity after baseline correction. Lifetime analysis used custom software to 
simulate exponential decays convolved with the measured IRF for fitting using nonlinear 
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least-squares (Levenberg-Marquardt algorithm.) For single dyes, a lifetime model was 
used: 
 ܨ(ݐ) = ܣ exp ൬−
ݐ − Δ
߬
൰ 4-1 
Where ܣ was the amplitude of fluorescence, ߬ was fluorescence lifetime, and Δ was a 
parameter accounting for time shift between the signal and the IRF.  
Mixtures were averaged across replicate wells and fit to: 
ܨ௝(ݐ) = ܥ௝൛ݔ௝ܣଵ exp  [− (ݐ − Δ) ߬ଵ⁄ ]
+  ൫1 − ݔ௝൯ ܣଶ exp  [− (ݐ − Δ) ߬ଶ⁄ ]ൟ 
4-2 
Where ݔ௝was the mole fraction in the ݆-th mixture and ܥ௝ was a scaling factor to 
account for intensity-dependent noise. Lifetimes ߬ଵ, ߬ଶwere globally constrained (283) to 
the values obtained for pure dye. Time shift Δ and amplitudes ܣଵ, ܣଶ were globally fit. 
Amplitude terms reflected the combined effect of extinction coefficient and quantum yield 
in the two dyes and fraction x represented the ratio of dye molecules. We found 
constraining the start (ݔ = 0) and end fractions (ݔ = 1) using single dyes improved fit 
accuracy. 
Raw first moments were defined as ∑ ݐ௜ܨ(ݐ௜)௜ ∑ ܨ(ݐ௜)௜⁄  and adjusted using 
exponential depression (297) to suppress noise at longer time intervals. We used the raw 
first moment ߤ଴ to calculate a depression function,  exp(− ݐ ߚߤ଴⁄ ). Larger ߚ values 
increased agreement of the moment and lifetime values, but decreased precision. We found 
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ߚ = 3 was sufficiently small to maintain precision. The adjusted first moment 
 ߤ =
1 + ߚ
ߚ
ቈ
∑ ݐ୧ exp(− ݐ௜ ߚߤ଴)⁄ ܨ(ݐ௜)௜
∑ exp (− ݐ௜ ߚߤ଴)⁄ ܨ(ݐ௜)௜
቉ 4-3 
was calculated by assuming that ܨ(ݐ) was an exponential function (Eq. 1). Integration 
of Eq. 3 by parts would then yield ߤ = ߬ in an ideal case where the IRF is infinitely steep. 
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4.4 Experimental Results 
The NovaFluor plate reader is a nanosecond time-resolved spectrometer that uses 
pulsed laser excitation, a high-speed digitizer and a photomultiplier tube (PMT) detector 
to record fluorescence decays from each well of a microplate. The digitizer read time is 
approximately 1 ms per waveform for a 5-kHz laser source (interleaving over 5 pulses) and 
the transport time is 0.3 s per well. Typical acquisitions were averaged across 200 
successive waveforms giving an acquisition rate of 0.5 s per well or 3 min per 384-well 
plate. We used single-lifetime dyes to determine the precision and resolution of the plate 
reader and to measure its signal-to-noise performance. 
4.4.1 Lifetime Compared with Intensity 
 We used water-soluble dyes with a variety of lifetimes to measure instrument 
performance (Fig. 25). First, we measured the instrument response function (IRF) in pure 
water. We then selected an appropriate emission filter and adjusted excitation power with 
a neutral density filter to give a peak signal of 50-150 mV. Total intensity was measured 
as the fluorescence decay integrated across all time points of the acquired waveform. 
Lifetime and moment were determined from the waveform (see Methods).  
The plate reader acquired lifetime data with better than 1% precision for dye lifetimes 
of 1.6 ns and higher. Precision was measured as coefficient of variation (CV = SD/mean). 
Lifetime measurements were up to 25-fold more precise relative to the simultaneous 
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measurement of total intensity. The ultra-short lifetime dye Rose Bengal fit to a single 
lifetime (0.04 ns) with low precision, although the standard deviation (11 ps) was 
comparable to that of other dyes. 
We measured the precision of lifetime detection by uniformly dispensing dye into 384-
well plates and measuring the DWR signal using the plate reader (Fig. 25). We fit the 
decays to a single exponential lifetime model (Eq. 1). We found rhodamine B lifetime had 
5-fold improved precision compared with total intensity, while the longer lifetime dyes 
rhodamine 6G and EDANS showed a 25-fold relative improvement in precision (Table 9). 
We would expect DWR to have better precision for lifetimes that are long relative to the 
IRF (2.8 ns FWHM), and this is consistent with our results. In most cases, we found that 
well-to-well precision improved when analyzing half of each plate (192 wells) due to 
systematic errors in volume of liquid dispensed.  
We also analyzed waveforms using first moment, a more direct analysis than the 
lifetime model. We found the raw first moment had poor precision and was sensitive to 
Table 9. Comparison of Precision for Intensity, Lifetime and Moment Measurements. 
 Intensity 
CV 
Lifetime 
(ns) 
Lifetime 
SD (ns) 
Lifetime 
CV 
Moment 
(ns) 
Moment 
SD (ns) 
Moment 
CV 
Rose Bengal 7.17% 0.040 0.011 27.50% 1.187 0.004 0.34% 
Rhodamine B 3.47% 1.566 0.010 0.67% 2.476 0.009 0.37% 
Rhodamine 6G 6.99% 3.914 0.011 0.27% 3.357 0.008 0.25% 
EDANS 2.74% 12.684 0.028 0.11% 10.197 0.014 0.14% 
Dyes were dispensed in uniform volume in microplates to measure signal precision across wells. 
Lifetime precision (coefficient of variation, CV = SD/mean) is superior to intensity precision in all but 
the shortest lifetime dye. Further enhancement of precision is seen in the adjusted first moment.  
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noise during the later fluorescence decay, even when we truncated the data. The adjusted 
first moment (Eq. 3) had greater precision than was seen in the fitted lifetimes. The absolute 
value of the moment differed from the value of lifetime and was affected by experimental 
conditions such as PMT voltage. 
 We examined variation between wells by comparing total intensity with lifetime and 
adjusted first moment (Fig. 26). Lifetime values for the dyes in Table 9 were mostly 
randomly distributed, showing weak correlation with intensity (Pearson’s correlation 
coefficient ݎ took values |ݎ| ≤ 0.5). Rhodamine 6G showed a moderately strong 
correlation (ݎ = 0.87) with intensity, although the coefficient of variation remained less 
than 1%. We hypothesize that these correlations reflect a small nonlinear response in the 
detector and/or digitizer.   
4.4.2 Linearity of Detection 
 Direct waveform recording requires fluorescence emission to be linearly related to 
signal intensity, since intensity-dependent variations could distort the waveform and fitted 
lifetime (292). We varied excitation power and sample concentration to determine whether 
nonlinearity affected instrument performance. First, we tested linearity of the total intensity 
measurement by reducing the excitation power in calibrated steps and measuring intensity 
of the ultra-short lifetime dye Rose Bengal, finding excellent agreement (Fig. 27). We 
defined an arbitrary unit of fluorescence as the total intensity of a given waveform with a 
100-mV peak signal. 
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 Next, we tested how fluorescence intensity varied with concentration of the short 
lifetime dye rhodamine B over a 50-950 nM range (Fig. 28) (a)) and found the expected 
linear relationship with a root-mean-squared deviation of 1.8%. For this experiment, each 
dye concentration was dispensed in 16 replicate wells. CV of intensity was 2%-6% in each 
set of replicates, and CV of lifetime was 1.64% across all wells, varying from 2.08% at 50 
nM to 0.87% at 950 nM. 
We further analyzed the effect of signal intensity on apparent lifetime by plotting 
lifetime and intensity for each well (Fig. 29). Lifetime values were increasingly variable 
below 0.5 A.U., while the instrument provided good precision for fluorescence signals in 
the range 0.5-1.5 A.U. The apparent lifetime showed a moderate positive correlation with 
intensity (ݎ = 0.70) despite the overall low CV (1.6%). This correlation had minimal 
impact on precision when intensity variation was due to experimental error alone. For 
example, the data in Fig. 26 span a range of ~1.0-1.2 A.U. with a lifetime CV of 0.7%. The 
lifetime of rhodamine B (1.6 ns) was short compared to the IRF (2.8 ns) and thus was more 
affected by instrument nonlinearity than were the longer lifetime dyes. 
4.4.3 Signal Quality 
The instrument response function (IRF) had a measured FWHM of 2.3 ns (full width 
at half maximum) with 355 nm excitation and 2.8 ns with 473 nm excitation (Fig. 24). In 
all experiments, we acquired waveforms at 1 GHz with the ATWD digitizer and increased 
the effective sample rate to 5 GHz by interleaving each cycle of 5 laser pulses (Fig. 30 (a)). 
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We calibrated a series of onboard pre-trigger delays in 0.2 ns steps so that the delay 
incremented with each laser pulse. We verified the delay calibration by recording 200 
successive 5 GHz waveforms of a rhodamine B sample and extracting the 1 GHz 
waveforms. We then fit the time delay relative to the IRF for each waveform and calculated 
mean offset values (Fig. 30 (b)). The observed offsets had better than 5% accuracy over 6 
months compared with calibrated values. 
The ability to precisely acquire lifetime data depends on the experimental signal-to-
noise ratio (SNR), typically measured at the peak of the fluorescence decay (280, 292). We 
acquired 1000 signal-averaged waveforms from a sample of rhodamine 6G to estimate 
instrument noise from the variation in a single well. We calculated the SNR waveform 
(Fig. 31 (a)) as the signal of one waveform divided by the standard deviation at each time 
point. Peak SNR was inversely related to the detector voltage. At the low PMT voltage 
(400 V, a detector gain of about 1000) SNR peaked at 580 and dropped to 360 at higher 
PMT voltage (500 V, a detector gain of about 5000). These values were far above the 
desired threshold for precise lifetime detection (SNR ≥ 100).  
The maximum signal-to-noise ratio was affected by the PMT voltage and the number 
of cycles averaged (Fig. 31 (b)). In the absence of averaging, SNR ranged from 40 at 400 
V acquisition to 90 at 500 V. Averaging over 200 cycles per acquisition increased SNR 
better than 6-fold. Experimental sources of variation between wells had a large effect on 
lifetime precision relative to instrumental sources. We found a 384-well plate of rhodamine 
6G that showed substantial well-to-well variation in observed lifetime (CV 1.62%) with 
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200 cycles of averaging showed nearly equal precision with 50 cycles of averaging (CV 
1.64%) despite the nearly 50% decrease in SNR per well. Pulse interleaving had a modest 
effect in the presence of experimental noise. Interleaved waveforms (5 GHz) of the short 
lifetime dye rhodamine B were more precise across wells (CV 0.59%) than the same 
waveforms without interleaving (1 GHz, CV 0.87%).  
4.4.4 Resolution of Lifetimes 
We tested the ability of the plate reader to resolve two dyes with similar lifetimes (1.6 
ns for rhodamine B and 3.9 ns for rhodamine 6G) and overlapping emission spectra by 
mixing the dyes in 384-well plate, incrementing the volume of each dye by 5% in each 
column of wells to maintain a total concentration of 1 M (Fig. 32). We averaged 16 
replicate wells at each concentration and fit the relative fraction of dye using a two-
component model (Eq. 2). The fit recovered the true fraction with high accuracy (root-
mean-squared deviation (RMSD) = 0.74% relative to the predicted mole fractions). The 
two-component mixture required averaging of replicate wells as fit results showed high 
variability (RMSD 2% or greater). Variability decreased to 1.08% RMSD with 4 replicates 
and 0.74% with 16. This result demonstrates the NovaFluor plate reader can resolve 
changes in lifetime with high accuracy, a key requirement for lifetime-based assays.  
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4.5 Discussion 
Direct waveform recording (DWR) enables fluorescence lifetime acquisition in a 
microplate with a signal-to-noise ratio (SNR) of 400 or better while maintaining acquisition 
rates of 0.5 s per well. The plate reader acquires waveforms with high precision across a 
range of lifetimes, from short (1.6 ns, rhodamine B) to long (12.7 ns, EDANS). While there 
is great interest in developing long lifetime probes to improve the resolution of lifetime 
assays (289), the high precision of DWR permits the use of short lifetime probes as well. 
The per-well precision of lifetime measurement is routinely near 10 ps allowing us to 
resolve small changes in lifetime with high precision. The width of the IRF (2.8 ns) was 
not a barrier to analysis of short lifetimes, although the ultra-short lifetime dye Rose Bengal 
was unsuitable.  
Fluorescence lifetime has a key advantage in high-throughput screening assays 
because it directly resolves interfering fluorescence signals (298) that are present in most 
screening compound libraries (299). The use of multiple-exponential fits to resolve 
compound interference is firmly established (278). We have shown (Fig. 32) that the DWR 
plate reader resolves the relative fraction present in a two-component mixture with better 
than 1% accuracy over a 20-fold concentration range, making it resistant to compound 
interference.  
Acquisition rate has been a key limitation in applying fluorescence lifetime to high-
throughput screening. We can compare DWR with photon counting methods of lifetime 
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detection by comparing peak SNR in each. In photon counting (280), SNR increases as 
√ܰ, while DWR measures SNR as signal/SD of successive waveforms (292). Photon 
counting applications have been optimized for a CV of 0.5% acquired in several hundred 
milliseconds (300). If we assume a single 4 ns lifetime and 0.2 ns bins, this measurement 
would have a peak channel photon count of about 5,000 corresponding to an SNR of 70. 
This is comparable to our performance with no signal averaging (Fig. 31) and at least 5-
fold worse than our actual SNR performance in a 0.5 s acquisition. In another example 
(290) a 5 MHz TCSPC instrument acquired 10,000 peak channel photon counts in 3 s, an 
SNR of 100. Increasing SNR to 400 would require ~50 s acquisition in this example. DWR 
provides SNR of 400 or greater in 200 ms (200 cycles averaged), at least 100-fold faster 
when compared with TCSPC. The transport time of the microplate stage (0.3 s) limits our 
plate reader to a per-well acquisition time of 0.5 s (200 cycles averaged).  With this 
limitation, the two methods are roughly comparable in speed. 
Several factors affect the per-well acquisition time. Waveform averaging provides 
some protection against fluctuations in the fluorescence signal on the ms time scale, e.g., 
due to motion of contaminating particulates. We routinely average 200 waveforms per 
well. Averaging is not necessary as instrument noise is quite low (~0.5 mV or less) 
providing high SNR. Reducing the number of waveforms to 50 modestly improves the 
acquisition time to 0.35 s, but may harm resolution. Similarly, pulse interleaving may be 
disabled to increase acquisition rate at a cost of decreased resolution of lifetime 
components. We are currently pursuing a rapid scan mode to decrease acquisition time to 
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0.1 s per well. Early results show SNR comparable to data acquired with 50 cycles 
averaged, a 3.5-fold improvement in speed. 
Cost is another limitation in high-throughput screening assays. We have used costly 
glass plates in this study, but have tested plastic plates (polystyrene or cyclic olefin 
polymer) finding their precision is comparable. Plastic plates generate autofluorescence 
that hinders lifetime resolution. Assays that do not require resolution of component mole 
fractions may therefore benefit from plastic plates. We have begun development of a top-
read format plate reader that enables use of lower cost polypropylene plates. Early results 
show comparable precision to that presented here (CV of lifetime better than 0.5%). 
Direct waveform recording relies on the linearity of the analog current generated by 
the PMT. While the total intensity signal of our instrument is linear with excitation power 
(Fig. 27) and concentration (Fig. 28), nonlinearity results in a correlation of apparent 
lifetime with intensity. The nonlinearity is likely due to physical limitations in the PMT at 
high peak output current (2 mA for a 100-mV signal). High intensity signals thus produce 
slightly longer lifetimes. The effect is small (~50 ps per fluorescence unit, Fig. 29). We 
find nonlinearity has negligible effect when intensity varies due to experimental error alone 
(Fig. 26) as per-well precision (~10 ps) becomes limiting. Assays requiring full dynamic 
range should consider the effect of nonlinearity on apparent lifetime. This effect is a subject 
of ongoing study. 
Other approaches to improving resolution of fluorescence assays include 
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homogeneous time-resolved fluorescence (HTRF) using long-lived lanthanide probes 
(301) or development of ratiometric assays that exploit changes in emission spectra, for 
example the ratio of donor to acceptor emission in a FRET pair (302). Both techniques 
limit the choice of probes available and do not eliminate the issue of signal precision 
common to intensity-based measurements. For applications requiring greater sensitivity 
and rejection of signal interference, enzyme-coupled bioluminescence assays remain the 
gold standard (298, 303). 
Fluorescence lifetime has been pursued for improvement of high-throughput screening 
assays for many years. The high precision of DWR has enabled development of new types 
of fluorescence assays including time-resolved transient kinetics (293) and the recently 
reported time-resolved flow cytometry measurement of single cells (304). The NovaFluor 
lifetime plate reader demonstrates that direct waveform recording achieves excellent 
signal-to-noise and per-well precision while providing fast acquisition rates suitable for 
drug screening and other high-throughput applications.  
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4.7 Figures 
 
  
Fig. 23. Fluorescence lifetime plate reader. 
The NovaFluor spectrometer uses an X-Y stage, pulsed laser, PMT and digitizer for direct waveform 
recording (DWR) of fluorescence lifetime decays. Excitation light is focused through a pinhole to the center 
of each well of a microplate. Fluorescence emission is collimated by a parabolic mirror and focused on the 
PMT. Fluorescence decays are digitized and acquired for lifetime or moment analysis. 
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Fig. 24. Direct Waveform Recording (DWR) of Fluorescence Decays.  
The instrument response function (IRF, black squares) acquired from scattering in water is shown with 
fluorescence decay waveforms for rhodamine B (blue triangles) and rhodamine 6G (red circles). Waveforms 
acquired by DWR at 400 V with 0.2 ns resolution. Signal does not start at time zero because pre-excitation 
data was used to adjust the Y-axis baseline for each normalized waveform. 
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Fig. 25. Fluorescence lifetime is more precise than fluorescence intensity.  
Intensity (black squares) and lifetime (red triangles) of rhodamine B (1 µM in water) were 
calculated from waveforms acquired in 192 wells of a 384-well microplate. Lifetime CV is 
0.7% (coefficient of variation = SD/mean), 5-fold more precise than intensity CV (3.5%) for 
this short lifetime dye. Left axis is total intensity divided by mean and right axis is centered 
and scaled in proportion. 
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Fig. 26. Lifetime and moment are precise across wells. 
Lifetime and adjusted moment of rhodamine B (1 µM in water) were calculated 
from the decay waveform in each well. CV was 0.67% (SD 10 ps) for lifetime 
and 0.22% (SD 9 ps) for moment.   CV (coefficient of variation) = SD/mean. One 
fluorescence unit = total intensity given a peak signal of 100 mV. 
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Fig. 27. Linear dependence of fluorescence on excitation power.  
Incident power was varied by a neutral density filter to excite Rose Bengal (1 µM in water) in a single well. 
Total intensity (red squares) varied linearly (ݎଶ > 0.999; RMSD 0.90%). Black line is the predicted 
relationship, scaled to the unit intensity of a waveform at 100 mV peak signal. 
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Fig. 28. Fluorescence is 
proportional to intensity.  
(a) Fluorescence total intensity (red 
squares) of rhodamine B (0-950 µM 
in water) varies linearly with 
concentration (ݎଶ > 0.999; RMSD 
1.8% relative to expected 
relationship shown in black line).  
(b) Intensity map of plate shown in 
false color with dye concentration 
ranging from 0 (left column) to 950 
µM (right column).  
(c) Lifetime map of the same plate, 
with empty wells assigned a lifetime 
of zero. 
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Fig. 29. Distribution of apparent fluorescence lifetime and intensity.  
Fitted lifetimes (red triangles) were precise (1.6% CV) across a range of dye concentrations (50-950 µM 
rhodamine B in water). The apparent correlation of lifetime and intensity reflects detector nonlinearity. CV 
= coefficient of variation (SD/mean).  
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Fig. 30. Pulse interleaving increases 
effective sampling rate.  
(a) The ATWD digitizer was 
calibrated to use a series of pre-trigger 
delays (black symbols: 0, 0.2, 0.4, 0.6 
and 0.8 ns) on successive laser pulses. 
Each sequence of five 1-GHz 
acquisitions was combined into a 
single 5-GHz interleaved waveform 
(red squares).  
(b) The true offsets (red circles) were 
measured by exponential fitting 
showing better than 5% agreement 
with calibrated values (X-axis), root-
mean-squared deviation 2.8%. 
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Fig. 31. Direct waveform 
recording provides high SNR. 
Signal-to-noise ratio (SNR, 
defined as signal/SD) was 
measured for 1000 successive 
acquisitions with 0.2 ns resolution.  
(a) SNR waveform of rhodamine 
6G (1 µM in water) acquired with 
200 cycle averaging of each 
waveform;  
(b) Representative values of peak 
SNR of rhodamine 6G with varied 
number of cycles averaged. Peak 
SNR was highest (580) at low 
PMT voltage (400 V, black 
squares) and dropped to 360 at 
high PMT voltage (500 V, blue 
diamonds). 
 121 
Fig. 32. Fluorescence lifetime 
quantitatively resolves dye mixtures.  
(a) Rhodamine 6G was mixed with 
rhodamine B in 5% volume steps (1 µM 
total, in water) for lifetime detection.  
(b) The mole fraction of rhodamine 6G 
was recovered with high accuracy by a 
two-component exponential fit (blue 
squares). Squared correlation 
coefficient ݎଶ > 0.999, root-mean-
squared deviation 0.74% relative to the 
predicted relationship ݔ = ݕ (black 
line).  
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5 Myosin Biosensors 
Myosin motor activity is essential for its physiological function. A crucial measure of 
motor activity is the local ensemble force (see discussion, p.90) that is proportional to the 
number of available motors in the ensemble multiplied by their duty ratio, i.e., the number 
of strongly-bound, force-generating motors. A FRET biosensor strategy was pursued to 
resolve the strongly-bound state of myosin (Fig. 22). Time-domain fluorescence lifetime 
measurements can resolve multiple species with excellent precision (Fig. 32). The ability 
to express the sensor in cells without additional labeling was also a high priority.  
Dictyostelium MhcA was tagged with a donor fluorescent protein at its N-terminus 
and RLC was fused with an acceptor fluorescent protein (Fig. 33). This design was 
predicted to show higher FRET in the pre-powerstroke, ATP-bound state and relatively 
lower FRET in the post-powerstroke, ADP-bound or apo states due to the motion of the 
lever arm and increased distance between the donor and acceptor molecules (Fig. 33C). 
Note that when actin is present, the pre-powerstroke states are associated with relaxation 
and the post-powerstroke states with rigor. The fluorescent MhcA and RLC were co-
expressed in mlcR– cells (305) to prevent competition between endogenous and fluorescent 
RLC molecules. The fluorescent RLC rescued the mlcR– developmental phenotype 
indicating that its function was unharmed by fusion with the mRFP acceptor (Fig. 33D).  
Finding that the two proteins were tolerated and expressed at high levels in 
Dictyostelium, cells expressing NowGFP-MhcA plus RLC-RFP-Δ93 or NowGFP-MhcA 
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plus WT RLC, were harvested (5 ∙ 108 cells each) in lysis buffer (50 mM HEPES, 2.5 mM 
EDTA, 1 mM DTT, pH 8.0) and lysed in 1% v/v Triton-X-100 (Anatrace). 
 Myosin was prepared by actin co-sedimentation and released with 20 mM MgATP 
(308). The partially purified myosin was dialyzed into assay buffer (10 mM Tris, 2 mM 
MgCl2, pH 7.0) for fluorescence lifetime assays. Rabbit skeletal muscle actin was prepared 
as described (309) except ATP was omitted. F-actin was stabilized with equimolar 
phalloidin (Sigma-Aldrich). 
 
Fig. 33. A Dictyostelium Myosin 2 FRET sensor. 
A fragment of DdMhcA encompassing the motor and light-chain binding domains (aa 1-821) with N-terminal 
7xHis and NowGFP tags (306, 307) was co-expressed with RLC-RFP-Δ93 (mRFP inserted between EF2 and 
EF3 subdomains). (A) Ribbon model of the pre-powerstroke (bent, lever up) conformation modeled using 
PDB: 1DFL. Upper and lower actin binding sites are at left; (B) Model of the post-powerstroke (straight, 
lever down) conformation (PDB: 1DFK); (C) Superimposition showing lever arm rotation; (D) Brightfield 
micrograph of mlcR– fruiting body formation rescued with RLC-RFP- Δ93 (red fluorescence is overlaid). 
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Fluorescence lifetime was measured as described (292) using TCSPC detection 
maintaining at least 100,000 peak channel photon counts. The donor-only myosin (i.e., 
myosin co-purified with WT RLC) had a lifetime of 4.42 ns (Fig. 34). Mixing donor-only 
myosin with 40 µM F-actin did not alter the donor fluorescence. This concentration of actin 
was chosen to approximate the ܭ௠ of ATPase activation. The concentration of myosin was 
not determined but was certainly less than 10 µM by comparison with purified fluorescent 
protein standards. Thus, actin was present in large excess to fully saturate myosin in rigor 
conditions. 
Fluorescence lifetime of the donor+acceptor myosin was 4.18 ns in rigor (Fig. 34) 
corresponding to a FRET efficiency of 5% compared to the donor-only control. This 
change, though large compared to the experimental precision, was much less than predicted 
based on measurements in intact cells with at least 20% FRET efficiency. This discrepancy 
 
Fig. 34. Time-domain Fluorescence of a Dictyostelium Myosin FRET Sensor. 
(Left) NowGFP-DdMhcA donor fluorescence is not affected by the presence (DA.M) or absence (DM) of 40 
µM F-actin; (Right) Donor fluorescence (DAA.M) is decreased in the presence of RLC-RFP-Δ93 acceptor. 
Intensity-weighted average lifetime was calculated from the 2-exponential decay model. Residual error (data 
minus fit) is plotted with 10-fold magnification below. IRF is plotted as the black curve. 
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could be due to bleaching of the acceptor during purification, nonspecific FRET in cells 
caused by excess unbound RLC, undesired intermolecular interactions with the acceptor, 
or dissociation of the RLC during purification. Bleaching is unlikely based on previous 
purification of GFP-MhcA with RFP-RLC (tagged at the N-terminus) that did not show a 
discrepancy between in vivo and in vitro FRET efficiency. Nonspecific FRET can be ruled 
out based on estimation of the minimum acceptor concentration required to affect the donor 
(310). Intermolecular interactions were ruled out by co-expression of the acceptor with 
soluble GFP or NowGFP donors, which did not significantly alter the in vivo donor 
lifetime. These results indicate that the RLC-RFP-Δ93 molecule dissociates from the light-
chain binding domain during purification, perhaps because the fusion protein has a reduced 
binding affinity for myosin. Attempts to improve retention of the RLC by concentrating 
the sample 5-fold during purification or increasing intermolecular crowding with 2% w/v 
methylcellulose (311) did not alter the result.  
Analysis of the fluorescence lifetime using a compartmental model (compartment 1 = 
donor-only; 2 = pre-powerstroke FRET distance; 3 = post-powerstroke FRET distance) 
found that the estimated donor-only fraction (apparently lacking the RLC acceptor) was 
80%. The average lifetime of 4.18 ns can be interpreted as a mixture of 80% donor-only 
(4.42 ns) and 20% donor+acceptor molecules.  
The in vitro fluorescence lifetime was analyzed in multiple biochemical conditions to 
validate the putative biosensor (Fig. 35). The excessively large donor-only fraction was 
controlled for using the compartmental model. Fluorescence amplitudes and lifetimes were 
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estimated from the donor-only fluorescence using a single exponential model. The Förster 
distance model (20) was then estimated, using two freely varying distance parameters. 
Mole fraction parameters were also freely varied for compartments 1 & 2.  
Approximately 75% of nucleotide-free 
myosin (apo, M) populated the pre-
powerstroke distance, shifting to 100% in 
M.ATP. Nucleotide-free myosin bound to 
40 µM F-actin (A.M) strongly favored the 
rigor conformation with only 25% 
remaining at the lever-up distance. 
A.M.ATP had an intermediate value, 
consistent with a mixture of weakly bound 
or detached (M.ATP) and strongly bound 
(A.M) myosin. The results clearly resolve 
the rigor (A.M) state from the apo (p = 
.0009), the detached ATP (p = .0006), and 
relaxation conditions (p = .001).  
The pre-powerstroke fraction in the apo state was different from rigor and most closely 
resembled the relaxation condition. This unexpected result suggests that the myosin 
recovery stroke (reverse powerstroke) may be thermodynamically favorable even in the 
absence of ATP. This result contrasts with previous reports using a Cys-lite DdMhcA 
 
Fig. 35. Motion of Myosin Light-Chain Binding 
Domain Reported by FRET. 
Conformation of the myosin FRET sensor was 
modeled as a distribution of two distances: pre-
powerstroke and post-powerstroke. M, myosin (apo); 
M.ATP, myosin plus 1 mM MgATP; A.M; myosin 
plus 40 µM F-actin (rigor); A.M.ATP, relaxation. 
Note that because the true distances are not defined, 
the values of 0% and 100% are arbitrary. Standard 
error bars are estimated from the fit. 
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sensor (260, 262). Future work will need to resolve this discrepancy perhaps with 
comparative measurements using varied labeling strategies to rule out effects of probe 
orientation (e.g., by circular permutation of the fluorescent protein structure). This result 
also demonstrates the importance of using a true rigor condition (A.M) to calibrate myosin 
biosensors rather than relying solely on detached states of myosin.
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6 Conclusions and Future Directions 
This work has focused on the cell biology of an unconventional myosin, DdMyo7, and 
biophysical methods for studying a conventional myosin, DdMhcA. The concerted 
application of molecular and cellular biophysics will be essential to discover how myosin 
motor proteins are activated for force generation within the cell and the specific 
mechanisms by which local tension generation and tension sensing by myosins impact their 
diverse physiological functions. 
6.1 Amoebozoan Myosin 7: A Model Filopodial Myosin 
Filopodia are commonly defined as dynamic cellular protrusions containing actin and 
the actin-bundling protein fascin. Fascin is required for filopodia formation in human cells. 
The recent identification of fascin in filopodia of Salpingoeca rosetta1, a choanoflagellate, 
suggests that the role of fascin in filopodia predates the evolution of animals (196, 198). 
The conserved animal proteins Dia2 and VASP are associated with filopodia and localize 
to their tips but are not essential for their formation (183, 312, 313). Myosin 10 is essential 
for filopodia formation in humans, but is lost in some invertebrates such as Drosophila 
melanogaster, raising the possibility that the filopodial functions of Myosin 10 can be 
                                                 
1 Identified as Proterospongia sp. in older literature but since reclassified. 
 129 
replaced by other MyTH4-FERM myosins such as Myosin 15 (314).  
Conservation of actin-based filopodia, as well as key proteins essential for filopodia, 
suggests that the molecular mechanism(s) of filopodia formation have also been conserved 
as a core function in migratory cells including animals, choanoflagellates and amoebae. 
The Amoebozoa branched from the fungal/animal lineage (Opisthokonta) prior to the 
evolution of fascin and Myo10, yet amoebae produce abundant dynamic filopodia with MF 
myosin at their tips. There is no protein equivalent to fascin in amoebozoan filopodia as 
Table 10. Comparison of Filopodial Myosins 
Feature Metazoa (Myo10) Amoebozoa (DdMyo7) 
Fascin essential for filopodia Yes (198) Fascin is not present 
VASP essential for filopodia No (183, 312) Yes (115) 
Actin filament length Long (≥ 500 nm) (315) Short, 100-200 nm (187) 
Effect of ΔFERM1 Domain is not present in Myo10 No strong effect; possibly shorter 
filopodia 
Effect of ΔFERM2 Increased extension velocity (219) Decreased extension velocity 
Effect of K/RxxK/R motif Motif is not present in Myo10 Negatively regulates filopod 
formation (208, 211) 
Effect of PIP3 binding Activation (210, 316, 317) Not required for activation 
Effect of talin binding Myo10 lacks proline-rich regions 
involved in talin binding 
Stabilizes talin in cytosol and 
promotes cell adhesion (161, 164) 
Effect of Motor/Lever arm 
expression 
Induces microspikes and/or 
filopodia (205, 318, 319) 
Does not induce microspikes or 
filopodia 
Effect of Tail expression Headless variant weakly localizes 
to membrane (320) 
Headless mutant strongly 
localizes to membrane/cortex  
Motor/Lever arm/MyTH4 is 
essential for filopodia 
Yes (112, 114, 212) 
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the known actin-bundling proteins appear to function redundantly. DdMyo7 is essential for 
filopodia formation like Myo10, but in most other respects resembles the holozoan Myo7 
or has unique features (Table 10). Chapter 2 shows that the DdMyo7 motor domain is 
unable to localize to filopodia without its lever arm (IQ motifs and SAH) and a conserved 
post-lever arm region (aa 1021-1115) (Fig. 36). The MyTH4-FERM domain is essential 
for localization to the actin cortex/membrane region and for full rescue of filopodia 
formation. A mutant protein containing only the first MyTH4 domain induced filopodia 
with low frequency, in contrast to the Myo10 ΔFERM mutant (retaining MyTH4) that can 
induce dorsal filopodia in HeLa cells at virtually the same frequency as full length Myo10 
(112). In myo7– cells expressing DdMyo7 chimeras, the Myo10 MF domain partially 
rescued filopodia formation while the Myo10 MyTH4 domain did not, suggesting that in 
Amoebozoa the FERM domain plays a direct role in promoting filopodia initiation while 
in animals the MyTH4 domain is sufficient. This would be consistent with specialization 
of the Myo10 FERM domain for interaction with membrane proteins such as the netrin 
receptor and β-integrins (100, 192) and perhaps also a reduced role for actin-binding by 
the FERM domain in fascin-based filopodia. Future studies must determine the specific 
molecular function of the MyTH4 domain in Myo10 and DdMyo7, which may represent a 
core conserved mechanism of filopodia formation in animals and Amoebozoa. It will also 
be interesting to test whether these motors are capable of bundling or clustering actin 
filaments, either through their motor domains, actin-binding sites on the FERM domains, 
or both. Changes in local actin filament organization may be keys to understanding the 
function of filopodial MF myosins. 
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Current models of filopodia initiation focus on the convergence of actin filament 
barbed ends, the ‘convergent elongation’ model (205, 321, 322). Motor activity of MF 
myosins is involved in filopodia initiation yet the mechanical role of the motor is unclear 
(323). The ability of MF domains to bind actin filaments suggests a model in which local 
tension generation by MF myosin pulls on actin filament ‘cargo’ bound to the FERM 
domain (Fig. 37). As the MF myosin moves toward the barbed end of its track, it would 
progressively recruit and orient cargo filaments in the direction of travel. DdMyo7 provides 
an excellent system to test this model since the interaction of DdMyo7 FERM domains 
with actin has been characterized (324) and DdMyo7 FERM domains appear to play a 
stronger role in initiating filopodia than does the Myo10 FERM. Initiation of fascin-based 
 
Fig. 36. Structure/Function of DdMyo7. 
  
Fig. 37. Proposed Model of Filopod Initiation in Dictyostelium. 
(A) Membrane-bound Rac1 activates DdMyo7 in the cytosol; (B) Activated DdMyo7 associates with the 
plasma membrane via its tail domain; (C) Membrane-bound DdMyo7 juxtaposes actin barbed ends and/or 
recruits VASP to barbed ends; (D) VASP increases the local density of free barbed ends through its anti-
capping and bundling activities, possibly assisted by recruitment of formin Dia2. The filopodium begins to 
extend as growing actin filaments push against the plasma membrane. 
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filopodia might occur through multiple paths including FERM-independent and VASP-
independent mechanisms, neither of which prevail in Dictyostelium. Thus, DdMyo7 is a 
natural model for an MF myosin-dependent mechanism of filopodia initiation. 
6.2 Myosin Biosensors: Combining Structure and Dynamics 
Looking forward, the primary consideration for Myosin 2 biosensors is the 
development of assays measuring the fraction of strongly-bound heads in relaxation, 
resolving the M.ATP and A.M.ATP states, since myosin will be ATP-saturated in most 
physiologically relevant contexts. This is currently feasible although sensitivity will be 
greatly improved by reducing the donor-only fraction and associated uncertainty in the 
model fit. Furthermore, the two-distance model is likely to be an oversimplification given 
evidence that the conformation and dynamics of myosin are altered in weakly-bound states 
compared to detached states (262, 325). It will be helpful to pursue in vitro experiments at 
saturating ATP over a range of actin concentrations, thereby varying the fraction of 
weakly-bound myosin, to further characterize the structure of these states. 
Finally, while optimization of myosin biosensors for low-duty ratio conventional 
myosins such as DdMhcA is an immediate goal, it should be noted that high-duty ratio 
motors such as Myo7, Myo10, and potentially DdMyo7, have a distinct advantage in FRET 
biosensor design because the strongly-bound state is dominant in actively cycling motors. 
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